{
  "methods": [
    "VAPOR DIFFUSION, HANGING DROP",
    "VAPOR DIFFUSION, SITTING DROP",
    "VAPOR DIFFUSION",
    "LIPIDIC CUBIC PHASE",
    "MICROBATCH",
    "BATCH MODE",
    "UNKNOWN",
    "EVAPORATION",
    "LIQUID DIFFUSION",
    "MICRODIALYSIS",
    "EVAPORATION, RECRYSTALLIZATION",
    "COUNTER-DIFFUSION",
    "SMALL TUBES",
    "HANGING DROP, VAPOR DIFFUSION"
  ],
  "components": [
    "HEPES",
    "TRISODIUM CITRATE",
    "CITRIC ACID",
    "AMMONIUM SULPHATE",
    "MAGNESIUM SULFATE",
    "THE CRYSTALLIZATION BUFFER WAS 100 MM BIS-TRIS BUFFER (ADJUSTED TO",
    "PEG 3350",
    "NA MALONATE",
    "TRIS-HCL",
    "SODIUM ACETATE TRIHYDRATE",
    "LITHIUM SULFATE",
    "SODIUM CITRATE",
    "SODIUM FORMATE 0.1M AMMONIUM ACETATE 0.1M SODIUM CITRATE TRIBASIC DIHYDRATE 0.1M POTASSIUM SODIUM TARTRATE TETRAHYDRATE 0.1M SODIUM OXAMATE",
    "HEWL",
    "NACL",
    "CHES",
    "24-30% PEG 4000",
    "20-28% PEG 4000",
    "26-32% PEG 4000",
    "28-30% PEG 4000",
    "MAGNESIUM FORMATE DIHYDRATE",
    "PEG2000 MONOETHYL ETHER",
    "MAGNESIUM ACETATE TETRAHYDRATE",
    "MES",
    "PACT G10 20% W V PEG3350;100MM BIS-TRIS PROPANE",
    "JCSG4-60 0.1 M HEPES",
    "MAGNESIUM CHLORIDE",
    "CITRATE",
    "AMMONIUM SULFATE",
    "MAGNESIUM FORMATE AND 20% W V PEG3350",
    "BIS-TRIS",
    "AMMONIUM ACETATE",
    "SODIUM POTASSIUM PHOSPHATE",
    "SODIUM FORMATE",
    "PEG3350",
    "MORPHEUS III (G7) 1.2 % CHOLIC ACID DERIVATIVES MIX 0.1 M BUFFER SYSTEM 2 7.5 50 % PRECIPITANT MIX 3",
    "1 UL OF PROTEIN SOLUTION (10 UG UL) WAS MIXED WITH 1 UL RESERVOIR SOLUTION (0.17 M AMMONIUM SULFATE",
    "SODIUM CHLORIDE",
    "W V 1",
    "SODIUM MALONATE",
    "SODIUM SULPHATE",
    "TRIS HCL",
    "1:1 RATIO OF 15 MG ML PROTEIN SOLUTION WITH A PRECIPITANT SOLUTION CONTAINING 20% PEG 6000",
    "1:1 RATIO OF A 15 MG ML PROTEIN SOLUTION WITH A PRECIPITANT SOLUTION CONTAINING 20% PEG 6000",
    "A 9 0.06 M DIVALENTS 0.1 M BUFFER SYSTEM 3 8.5 30 % V V PRECIPITANT MIX 1 0.06 M MAGNESIUM CHLORIDE HEXAHYDRATE; 0.06 M CALCIUM CHLORIDE DIHYDRATE",
    "PEG 1",
    "NANO3",
    "AMMONIUM SULFATE 0.1 M SODIUM ACETATE -> SOAKING EXPERIMENT BY PH ADJUSTMENT TO",
    "TRIS 8 PH",
    "34-41 %(V V) PEG400",
    "SODIUM ACETATE:HCL",
    "0.2 UL 17 MG ML PROTEIN IN 50 MM HEPES",
    "0.2 UL 19 MG ML PROTEIN IN 50 MM HEPES",
    "0.2 UL 16 MG ML PROTEIN IN 50 MM HEPES",
    "0.2 UL 18 MG ML PROTEIN IN 50 MM HEPES",
    "W V PEG 8K",
    "PEG MME 2000",
    "1 UL OF ANC4+LOOP II+P12K N13H (6.0 MG ML IN 10 MM SODIUM ACETATE",
    "1 UL OF ANC4+LOOP II+P12K N13H S58T N193G Y194F D197R (6.0 MG ML IN 10 MM SODIUM ACETATE",
    "BUFFER = 0.1M TRIS (7.8)",
    "TRIS-HCL (",
    "2 UL 40 MM SODIUM CACODYLATE",
    "LISO4",
    "SYNGUAB3-C222S CRYSTALS WERE GROWN IN THE PRESENCE OF IMP AND NAD+ IN MOTHER LIQUOR FROM THE CONDITION 2-48 OF THE COMMERCIAL SCREEN MORPHEUS (MOLECULAR DIMENSIONS)",
    "BIS TRIS",
    "TRIS BUFFER",
    "LITHIUM CHLORIDE",
    "PEG 4000",
    "NA ACETATE (",
    "8-12 % PEG 8000",
    "MORPHEUS BUFFER SYSTEM 3",
    "NA2SO4",
    "1",
    "AMMONIUM SULFATE 0.1 M TRIS-HCL (",
    "POTASSIUM NITRATE 20% PEG 3350",
    "SODIUM FLUORIDE 20% PEG 3350",
    "20-25 % (W V) PEG 6000",
    "BIS-TRIS (",
    "POTASSIUM PHOSPHATE CITRATE",
    "MES 6.5",
    "SODIUM PHOSPHATE MONOBASIC MONOHYDRATE",
    "AMMONIUM PHOSPHATE DIBASIC",
    "V V TACSIMATE",
    "K NA PO4",
    "MGAC2",
    "BICINE (",
    "AMACETATE",
    "MGCL2 HEXAHYDRATE",
    "SODIUM ACETATE",
    "SODIUM CITRATE TRIBASIC DIHYDRATE 1M ISOPROPANOL 20% PEG 4K 20%",
    "NA3CITRATE",
    "DI-AMMONIUMHYDROGEN CITRATE",
    "CACL2",
    "UREA",
    "PEG6000 10% ETHYLENE GLYCOL 0.1M TRIS",
    "TRIS",
    "PROTEIN IN 25MM TRIS HCL",
    "SODIUM CACODYLATE",
    "AMMONIUM ACETATE 100MM MES",
    "POTASSIUM PHOSPHATE",
    "CACL2 100 MM HEPES 30% MPD",
    "SODIUM CITRATE TRIBASIC DEHYDRATED",
    "ENZYME IN 50 MM NAPI",
    "W V PEG 4000",
    "PEG SMEAR HIGH",
    "7-14% (V V) 2-METHYL-2",
    "TRIS (",
    "LICL",
    "10-12 MG ML PROTEIN IN 25 MM TRIS HCL",
    "CAPS (",
    "28-31% PEG4000",
    "KH2PO4",
    "V V PEG 6000",
    "IMIDAZOLE   MES",
    "BICINE",
    "SODIUM NITRATE",
    "AMMONIUM CITRATE TRIBASIC 20% PEG 3350",
    "0.2 UL 10.2 MG ML FPHI (20MM TRIS",
    "MGCL2",
    "PEG6000",
    "PEG5000MME",
    "RNA",
    "PEG 5000 MONOMETHYL ETHER",
    "AMMONIUM SULFATE IN 0.1 M SODIUM ACETATE",
    "AMMONIUM SULFATE IN 0.1 M SODIUM CITRATE",
    "TRIS-HYDROXYCHLORIDE",
    "JCSG",
    "30-33% PEG4K",
    "PEG6000 -- 10% ETHYLENE GLYCOL -- 0.1M HEPES",
    "0.8 NACL",
    "PEG4000",
    "NAAC",
    "PEG 1000",
    "AFSSFN SYNTHETIC PEPTIDE (GENSCRIPT) WAS DISSOLVED TO 30 MG ML IN WATER AND CRYSTALLIZED BY HANGING DROP AT A 1:2 RATIO WITH 20% PEG 8000",
    "PEG1500",
    "PEG 3550",
    "V V MPD",
    "PEG 1500",
    "PROTEIN SOLUTION : PROTEIN 24MG ML",
    "PROTEIN CONCENTRATION 4.1 MG ML. RESERVOIR: TRISHCL",
    "250 NL OF DL-TNFR-1 CRD2 (25 MG ML) AND 250 NL OF PRECIPITANT (1.5 M SODIUM CHLORIDE",
    "PEG3350 18% W V",
    "PROTEIN CONCENTRATION",
    "BISTRIS (6.4)",
    "0.4UL PROTEIN PLUS 0.4 UL 100MM BIS-TRI",
    "13.5-15% PEG 6000 (W V)",
    "KBR",
    "PEG 8000",
    "CALCIUM ACETATE HYDRATE",
    "MOLECULAR DYNAMICS MORPHEUS SOLUTION CONTAINING 0.12M ETHYLENE GLYCOLS MIX",
    "PEG 4",
    "MES TRIS",
    "PEG8000",
    "CACL 2",
    "ETHYLENE GLYCOL",
    "PEG4K",
    "V V JEFFAMINE ED-2001",
    "AMSO4 1 M LISO4 0.1 M TRISODIUM CITRATE",
    "8-11 % PEG8000",
    "MAGNESIUM CHLORIDE HEXAHYDRATE",
    "HEPES (",
    "NAOAC",
    "AMMONIUM SULFATE; 0.1 SODIUM ACETATE",
    "1 UL 12 MG ML PROTEIN + 1 UL 21% (W V) PEG 1500",
    "MES MONOHYDRATE",
    "AMMONIUM FLUORIDE",
    "0.12M-0.21M NA2SO4",
    "GLYCINE",
    "PEG SMEAR MEDIUM",
    "IMIDAZOLE",
    "AMMONIUM FORMATE",
    "GLY-GLY",
    "AMMONIUM SULFATE 0.1 M SODIUM ACETATE (SOAKING AT",
    "25%PEG 3",
    "MGSO4 AND 20% PEG3350",
    "CITRIC ACID BUFFER",
    "LITHIUM SULFATE MONOHYDRATE",
    "PEG 1000 11.5% PEG 3350 11.5% MPD 0.09 M NPS 0.1 M MES-IMIDAZOLE",
    "HEPES SODIUM",
    "DISODIUM MALONATE",
    "LI2SO4",
    "25 MG ML",
    "MORPHEUS D3: 20%(V V) GLYCEROL",
    "PEG 500 MME",
    "MORPHEUS B4: 12.5%(V V) MPD",
    "PACT B4: 0.1M MIB (SODIUM MALONATE DIBASIC MONOHYDRATE",
    "MORPHEUS F4: 12.5% PDB 1000",
    "CALCIUM CHLORIDE DIHYDRATE",
    "POLYETHYLENE GLYCOL MONOMETHYL ETHER 2000",
    "PEG 20000",
    "2-2.5 M SODIUM ACETATE",
    "SPG BUFFER (0.1 M SUCCINIC ACID",
    "SPG BUFFER (SUCCINIC ACID",
    "1 UL PROTEIN SOLUTION (10 MG ML GMHA",
    "HEPES-NA BUFFER",
    "MB(H64G",
    "CA(AC)2 0.1 M",
    "PEG 6000",
    "THE CK2ALPHA' SOLUTION AFTER PROTEIN PURIFICATION (5 MG ML CK2ALPHA' IN 500 MM NACL",
    "HCAII WITH LIGAND (AT 1:1 MOLAR RATIO) IN 50 MM DEUTERATED TRIS BUFFER AND 2.7-3.0 M AMMONIUM SULFATE AT",
    "PROTEIN",
    "AMMONIUM FORMATE 0.2 M AND PEG 3350 20%",
    "MES (",
    "PEG 20000 16-26%",
    "HEPES 7.5",
    "TRIS 0.1 M",
    "(NH)4CL 0.2 M PEG3350 20-24%",
    "BIS-TRIS PH=7.0 150 MM AMSO4 GRADIENT 20-30% PEG3350",
    "DL-MALIC ACID",
    "(PEGSII-A10) 0.1M MGCL2",
    "(INDEX-H6) 0.2M SODIUM FORMATE",
    "(NH4)2SO4; 25% PEG4000",
    "AMMONIUM SULFATE 0.2M PEG 400 30%",
    "1.36 NA K TARTRATE",
    "W V PEG8000",
    "PEG 400",
    "NA FORMATE",
    "PEG 4K",
    "PROTEIN SOLUTION: 11 MG ML MST3 IN 25 MM HEPES",
    "ZNCL2",
    "KNO3",
    "CALCIUM ACETATE",
    "SODIUM PHOSPHATE",
    "20-40 MM AMMONIUM NITRATE",
    "W V POLYETHYLENE GLYCOL 8000",
    "W V POLYETHYLENE GLYCOL 20000",
    "SUCCINIC ACID",
    "BIS-TRIS + 25 % (W V) PEG 3350",
    "MAGNESIUM ACETATE",
    "(NH4)2SO4 12% GLYCEROL 0.1M TRIS PH=8.0",
    "0.7-0.9M LITHIUM SULFATE",
    "NACL WITH 0.1 M SODIUM ACETATE BUFFER (",
    "LITHIUM SULFATE 0.1 M TRIS-CL",
    "15-20% PEG 4K",
    "(NH4)SO4",
    "(NH4)2SO4",
    "0.18-0.25 TMAO 0.1 M TRIS HCL 21-23% W V PEG MME 2000",
    "L-SODIUM POTASSIUM TARTRATE WITH 0.1 M ADA BUFFER (",
    "NA3 CIT",
    "DEGLYCOSYLATED PROTEIN IN 25MM HEPES NAOH",
    "0.15 UL 9.1 MG ML FPHH (10MM HEPES",
    "W V LIDOCAINE HYDROCHLORIDE MONOHYDRATE",
    "0.15 - 0.22 M NANO3 20- 31 % (W V) PEG 3350",
    "0.15 - 0.22 M NANO3",
    "BISTRIS",
    "NAFORMATE 10% GLYCEROL",
    "AMMONIUM CITRATE TRIBASIC",
    "PEG 1500 AND 0.1 M SODIUM MALONATE DIBASIC MONOHYDRATE",
    "USING A COMMERCIAL CRYSTAL SCREEN (HAMPTON RESEARCH",
    "BEF3- GSA COMPLEXES WERE OBTAINED UNDER VAPOUR DIFFUSION SITTING DROP CONDITIONS. PROTEIN BUFFER (HRAS PY64 OR HRAS 0.4 MM",
    "PROTEIN BUFFER (PHOSPHO-HRAS PY64 0.4 MM",
    "MPD",
    "HEPES-NAOH BUFFER (",
    "MORPHEUS E4: 12.5%(V V) MPD",
    "MORPHEUS E6: 20%(V V) ETHYLENE GLYCOL",
    "IMADAZOLE (",
    "SODIUM CHLORIDE + 1.55 M AMMONIUM SULFATE",
    "POTASSIUM-SODIUM TARTRATE IN 25 MM HEPES BUFFER",
    "POLYETHYLENE GLYCOL (PEG) 3350",
    "- 0.1 M HEPES",
    "K2HPO4 NAH2PO4",
    "CITRATE BUFFER",
    "PEG400(10%-25%)",
    "PEG400 (10%-25%)",
    "NAKTARTRATE",
    "NAKTARTRATE 100 MM TRIS HCL",
    "SODIUM FORMATE AND 0.1 M HEPES BUFFER AT",
    "SUCCINIC ACID AT",
    "2-METHYL-2",
    "PEG 3350 (SIGMA-ALDRICH)",
    "2-PROPANOL",
    "PEG 2K",
    "1 PART PROTEIN SOLUTION (30MM TRIS",
    "ZINC ACETATE 0.1 M SODIUM CACODYLATE",
    "NA K PHOSPHATE",
    "PEG 200",
    "SUCCINATE",
    "POLYETHYLENE GLYCOL MONOMETHYL ETHER 550",
    "[40 MM SODIUM PROPIONATE",
    "PROTEIN IN 20MM TRIS HCL",
    "PEGSH",
    "7-8 MG ML PROTEIN IN 20MM TRIS HCL",
    "27-33% PEG 4000",
    "18 - 26% (W V) POLY(ETHYLENE GLYCOL) 3350",
    "ENZYME CONCENTRATED WITH 10MM L-CAPTOPRIL. PRECIPITANT: 18 - 26% (W V) POLY(ETHYLENE GLYCOL) 3350",
    "PROTEIN INCUBATED WITH 10 MM 1-HYDROXYPYRIDINE-2(1H)-THIONE-6-CARBOXYLIC ACID. PRECIPITANT: 18 - 26% (W V) POLY(ETHYLENE GLYCOL) 3350",
    "MORPHEUS CRYSTALLISATION KIT CONDITION C1; 40% V V PEG 500* MME; 20% W V PEG 20000. THE CRYSTAL WAS INCUBATED WITH 1MM MIXTURE OF CIS (1R",
    "MOPS HEPES",
    "SODIUM ACETATE TRIHYDRATE; 0.1 M SODIUM CACODYLATE",
    "HEPES NAOH",
    "SODIUM ACETATE (",
    "W V POLYETHYLENE GLYCOL 3",
    "MAGNESIUM FORMATE",
    "V V (+ -)-2-METHYL-2",
    "PROTEINASE K WAS DISSOLVED AT",
    "SODIUM FLUORIDE 0.1 M BIS-TRIS PROPANE",
    "PEPTIDE WAS DISSOLVED IN 30% ACETONITRILE AT 0.2 MG ML CONCENTRATION AND INCUBATED AT 310K",
    "PEPTIDE WAS DISSOLVED IN 10% ETHANOL AT 0.5 MG ML CONCENTRATION",
    "EFIAWL WAS DISSOLVED IN 0.15 - 0.5 MG ML CONCENTRATION IN A SOLUTION CONTAINING 30 % ACETONITRILE AND 0.1 % TFA AND INCUBATED AT 310K FOR SEVERAL WEEKS.",
    "LYOPHILIZED PEPTIDE WAS DISSOLVED IN 0.15 - 0.5 MG ML CONCENTRATION IN A SOLUTION CONTAINING 30% ACETONITRILE AND 0.1 % TFA AND INCUBATED AT 310K FOR SEVERAL WEEKS.",
    "LITHIUM SULPHATE",
    "POTASSIUM CHLORIDE",
    "0.3 UL PROTEIN + 0.3 UL CRYSTALLIZATION SOLUTION (0.2 M AMMONIUM CITRATE",
    "POTASSIUM CITRATE TRIBASIC MONOHYDRATE",
    "NPS MIX (0.3 M SODIUM PHOSPHATE DIBASIC DIHYDRATE",
    "2.0 %V V TACSIMATE (",
    "A RACEMIC MIXTURE OF L-AUREOCIN A53 AND D-AUREOCIN A53 AT 40 MG ML CONCENTRATION WAS MIXED 1:1 WITH 0.2 M AMMONIUM SULPHATE",
    "A RACEMIC MIXTURE OF L-AUREOCIN A53 AND D-AUREOCIN A53 AT 40 MG ML CONCENTRATION WAS MIXED 1:1 WITH 0.2 M AMMONIUM ACETATE",
    "A RACEMIC MIXTURE OF L-AUREOCIN A53 AND D-AUREOCIN A53 AT 40 MG ML CONCENTRATION WAS MIXED 1:1 WITH 0.7 M SODIUM CITRATE",
    "AMMONIUM SULFATE 0.1 M BICINE",
    "AMMPO4",
    "AMMSO4",
    "AMMONIUM SULFATE 100 MM HEPES",
    "AMMONIUM SULFATE 0.1M HEPES",
    "AMM2HPO4",
    "MOLECULAR DIMENSIONS MORPHEUS CONDITION 1-1: 30% PRECIPITANT MIX 1 (30% PEG 500 MME; 20% PEG 20000)",
    "MCSG-3 CONDITION A1: 20% PEG 8000",
    "#23 OF JBSCREEN NUC-PRO 1 (JENA BIOSCIENCE) 15% PEG4000",
    "TRIGLYCINE ADDED TO THE PROTEIN PRIOR TO CRYSTALLISATION. MORPHEUS SCREEN",
    "WIZARD CRYO 2#30: 40% PEG 600",
    "PEG 2KMME",
    "SODIUM FORMATE AND 0.1 M HEPES",
    "SODIUM HEPES",
    "INDEX D3: 0.1M HEPES",
    "MORPHEUS A12: 12.5% PEG 1000",
    "MORPH C8: 12.5% PEG1K; 12.5% PEG 3350; 12.5% MPD; 0.03M EACH NPS (NANO3",
    "TRI-SODIUM CITRATE",
    "LITHIUM ACETATE DIHYDRATE",
    "PEGION A4: 0.2 M LITHIUM CHLORIDE",
    "PEGION A1: 0.2 M SODIUM FLUORIDE 20% W V POLYETHYLENE GLYCOL 3",
    "PEG 2K MME",
    "AMMONIUM CITRATE DIBASIC",
    "MATURE CATHEPSIN L AT A CONCENTRATION OF 7 MG ML WAS EQUILIBRATED AGAINST 27% W V PEG 8000",
    "LICL 0.1 M SODIUM ACETATE TRIHYDRATE",
    "PEG3350 0.1 M BIS-TRIS",
    "ADC-33 (3.5 MG ML) IN 25% W V POLYETHYLENE GLYCOL (PEG) 1500",
    "ADC-162 (3.5 MG ML) IN 25% W V POLYETHYLENE GLYCOL (PEG) 1500",
    "SPG",
    "ADC-30 (3.5 MG ML) IN 25% W V POLYETHYLENE GLYCOL (PEG) 1500",
    "PROTEIN SOLUTION: 10 MG ML IN 25 MM HEPES",
    "MALONATE-IMIDAZOLE-BORATE",
    "MAGNESIUM CHLORIDE HEXAHYDRATE 0.1 M TRIS HYDROCHLORIDE",
    "22 %V V PEGSB",
    "SODIUM ACETATE TRIHYDRATE [NAACET]",
    "20.0 %W V POLYETHYLENE GLYCOL 3350 [PEG 3350]",
    "POTASSIUM PHOSPHATE MONOBASIC",
    "KCL",
    "PEG3350 AND 0.2 M AMMONIUM IODIDE",
    "PEG3350 AND 0.2 M AMMONIUM CITRATE",
    "POTASSIUM NITRATE",
    "BIS-TRIS; 20% (W V) PEG MME 2000;",
    "W V JEFFAMINE ED-2001",
    "POLYETHYLENE GLYCOL 10000",
    "6-10MG ML AND CRYSTALLIZED WITH THE SOLUTION WITH 0.1M NA ACETATE (",
    "PHOSPHATE-CITRATE",
    "PEG 6000 AND 0.1M TRI-SODIUM CITRATE",
    "THE PROTEIN IN COMPLEX WITH DUMP AND RALTITREXED WAS CRYSTALLIZED IN DROPS CONTAINING 1 UL PROTEIN SOLUTION (10 MG ML PROTEIN + 5 MM DUMP + 5 MM RALTITREXED INCUBATED AT 4 DEGREES FOR 4 H) AND 1 UL RESERVOIR SOLUTION (100 MM BIS-TRIS",
    "THE VHH CAFFEINE COMPLEX WAS CRYSTALLIZED USING THE HANGING-DROP VAPOR DIFFUSION METHOD. THE DROPS CONTAINED 2 MICROLITERS OF THE 20 MG ML COMPLEX AND 2 MICROLITERS OF THE WELL MOTHER LIQUOR WHICH CONTAINED 0.1 M BIS-TRIS (",
    "SODIUM FORMATE 0.1 M HEPES BUFFER",
    "THE CRYSTAL OF VASIP WAS GROWN IN THE DROP CONTAINING 1.4 UL PROTEIN SOLUTION (60 MG ML IN 10 MM HEPES",
    "PEG 4000 + 0.2 M LITHIUM CHLORIDE + 0.1 M TRIS-HCL",
    "MAGNESIUM CHLORIDE 0.1 M TRIS HYDROCHLORIDE",
    "AMMONIUM ACETATE 0.1 M TRIS HYDROCHLORIDE",
    "SODIUM CITRATE TRIBASIC DIGYDRATE",
    "KI 200 MM PEG 3350 20%",
    "PEG 6000 20% (W V)",
    "SODIUM SULFATE",
    "PEPTIDE",
    "4 UL OF PROTEIN (10 MG ML PFL-AE-CCR8 IN 12.5 MM HEPES",
    "SODIUM CHLORIDE AND 0.1 M SODIUM ACETATE",
    "LITHIUM SULFATE 0.1 M TRIS: HCL",
    "SODIUM CACODYLATE TRIHYDRATE",
    "NA-ACETATE",
    "ADA",
    "10-20 MM NICL2",
    "1.4-1.6 M SODIUM MALONATE",
    "PEG 2000 MME",
    "AMMONIUM SULFATE AND 0.1 M TRIS",
    "MG FORMATE",
    "OF ACETIC ACID-SODIUM ACETATE BUFFER (",
    "PROTEIN SOLUTION: ING3 PHD AT 20 MG ML IN TRIS 20 MM PH = 6.5",
    "TRIS 1.6 M NATRIUM CITRATE",
    "NACL AND 100 MM ACONA",
    "SODIUM ACETATE 20% POLYETHYLENE GLYCOL 3350",
    "SODIUM THIOCYANATE",
    "20-30% PEG4000",
    "0.15 - 0.22 M NANO3 20 - 31 % (W V) PEG 3350",
    "V V PEG500*MME;10% W V PEG 20000",
    "PURIFIED PAPS REDUCTASE FROM METHANOTHERMOCOCCUS THERMOLITHOTROPHICUS AT A CONCENTRATION OF 20 MG.ML-1 WAS ANAEROBICALLY CRYSTALLIZED INSIDE A COY TENT (N2 H2 AT A 96:4 RATIO) UNDER YELLOW LIGHT CONDITION. 0.7 UL OF PAPSR IN 25 MM TRIS HCL",
    "RESERVOIR SOLUTION: 50 MM MES (",
    "CA(OAC)2",
    "POLYETHYLENE GLYCOL 8000",
    "CRYSTALLISATION WAS PERFORMED ANAEROBICALLY AT 20 DEGREE CELSIUS USING THE SITTING DROP METHOD ON 96-WELL MRC 2-DROP POLYSTYRENE CRYSTALLISATION PLATES (SWISSCI) IN A COY TENT CONTAINING A N2 H2 (97:3%) ATMOSPHERE. THE RESERVOIR CHAMBER WAS FILLED WITH 90 UL OF CRYSTALLISATION CONDITION AND THE DROP WAS FORMED BY SPOTTING 0.55 UL PROTEIN WITH 0.55 UL OF 20% (W V) PEG 3",
    "CRYSTALLISATION WAS PERFORMED ANAEROBICALLY BY INITIAL SCREENING AT 20 DEGREE CELSIUS USING THE SITTING DROP METHOD ON 96-WELL MRC 2-DROP POLYSTYRENE CRYSTALLISATION PLATES (SWISSCI) IN A COY TENT CONTAINING A N2 H2 (97:3%) ATMOSPHERE. THE RESERVOIR CHAMBER WAS FILLED WITH 90 UL OF CRYSTALLISATION CONDITION",
    "LITHIUM SULPHATE; 0.1 M TRIS-HCL",
    "MORPUEUS B9: 20%(V V) PEG 500 MME",
    "MORPUEUS A10: 20%(V V) ETHYLENE GLYCOL",
    "MORPUEUS G9: 20%(V V) PEG 500 MME",
    "MORPUEUS C9: 20%(V V) PEG 500 MME",
    "BERKELEY G2: 45% MPD",
    "BERKELEY H6: 20% (W V) PEG 1500",
    "MORPHEUS H4: 12.5%(V V) MPD",
    "PEG 3350 0.2 M SODIUM CHLORIDE 0.1 M TRIS-HCL",
    "PEG 300",
    "PEG 3",
    "CALCIUM CHLORIDE",
    "SPG BUFFER",
    "PEG400",
    "MES-NAOH (",
    "BIS-TRIS PROPANE (",
    "W V PEG3350 0.18M TRIAMMONIUM CITRATE",
    "C2H3NAO2",
    "PEG-300",
    "SODIUM CITRATE TRIBASIC DIHYDRATE 0.01 M TRIS",
    "2.9M~3.9M SODIUM FORMATE",
    "A CRYSTAL WAS SOAKED INTO THE PRECIPITANT-FREE SOLUTIONS CONTAINING 40% DMSO",
    "MO",
    "SODIUM ACETATE 0.2 M AMMONIUM SULFATE 11 % PEG2000",
    "JEFFAMINE M60C",
    "SODIUM ACETATE 0.2 M AMMONIUM SULFATE 18 % PEG2000",
    "AMMONIUM ACETATE; 0.1M BIS_TRIS",
    "MONOSACCHARIDES (0.02 M EACH OF D-GLUCOSE",
    "ALCOHOLS (0.02 M EACH OF 1",
    "PROTEIN WAS CONCENTRATED TO 2.5 MG ML IN 20 MM TRIS",
    "THE CRYSTALLISATION BUFFER WAS 100 MM BIS-TRIS BUFFER (ADJUSTED TO",
    "FOR CRYSTALLISATION",
    "PEG1000 AND 0.1M TRIS",
    "SODIUM MALATE",
    "BICINE [",
    "5 UL OF 0.6 M SODIUM CHLORIDE IN 100 MM SODIUM ACETATE BUFFER",
    "5 UL 24% POTASSIUM SODIUM PHOSPHATE",
    "2 UL 1 M AMMONIUM SULFATE + 2 UL 10 MG ML PROTEINASE K IN 50 MM TRIS",
    "ADA AND 40% PEG-200",
    "AMMONIUM ACETATE 0.1 M SODIUM ACETATE",
    ".2 M MAGNESIUM CHLORIDE 0.1 M TRIS HYDROCHLORIDE",
    "AMMONIUM ACETATE 1.0 MM TCEP 3.0 MM CADMIUM SULFATE 0.1 M HEPES",
    "MONOSODIUM PHOSPHATE AND 0.75 M SODIUM CITRATE",
    "NH4OAC",
    "10 MG IN 20-30% MPD SOLUTION",
    "10 MG IN 20 % MPD SOLUTION (CACODYLATE BUFFER + 0.01 M MGCL2)",
    "SODIUM ACETATE 4.5",
    "LICL 0.1 M CITRATE",
    "W V PEG 1000",
    "37",
    "LYSOZYME",
    "PROTEIN: 0.5 MM SP30:HUMRADA22 IN 20 MM CHES",
    "IMIDAZOLE (",
    "PEG 3350 AND 0.1 M BIS-TRIS",
    "KSCN",
    "(TRIS (BASE); BICINE)",
    "(SODIUM HEPES; MOPS (ACID))",
    "(IMIDAZOLE; MES MONOHYDRATE (ACID))",
    "PROTEIN AT 5.2MG ML IN 10MM SODIUM PHOSPHATE",
    "TRIS-HCL AT",
    "2.6-3.0 M AMMONIUM SULFATE IN 50 MM TRIS-SULFATE (",
    "AMCASE CATALYTIC DOMAIN 20% W V PEG 6000 0.1 M SODIUM ACETATE",
    "HEPES SODIUM SALT",
    "UNDER THE CONDITION OF 2000 MM AMMONIUM SULFATE",
    "1.5 MM DNA WATER SOLUTION MIXED 1:1 V  V WITH 10% MPD",
    "LIGAND FREE DPPE WAS CRYSTALLISED IN A SITTING DROP FORMED BY MIXING 150 NL OF THE UNLIGANDED PROTEIN AT 9 MG.ML-1 WITH 150 NL OF 0.1 M MIB BUFFER",
    "ETHYLENE GLYCOL 0.1 M SODIUM ACETATE",
    "10-15% PEG3350",
    "DNA DUPLEX ANNEALED IN 7.5 MM HEPES",
    "DNA DUPLEX WITH 3 MM DB1976 ANNEALED IN 7.5 MM HEPES",
    "PROTEIN: 3.3 MG ML",
    "PROTEIN IN 50 MM AMMONIUM N-[TRIS(HYDROXYMETHYL)METHYL]-2-AMINOETHANESULFATE BUFFER WITH 0.25 MM EDTA",
    "PEG3000 AND 100MM CHES SODIUM HYDROXIDE",
    "SODIUM ACETATE BUFFER",
    "RESERVOIR SOLUTION: 0.1M TRIS",
    "RESERVOIR SOLUTION: 0.1 M TRIS",
    "PEG 10K",
    "11-13% PEG 8000",
    "POTASSIUM SODIUM TARTRATE",
    "PROTEIN: 8.5 MG ML",
    "PROTEIN: 5.6 MG ML",
    "PEG3350; 0.1M BIS-TRIS",
    "TRISCL 2M AMMONIUM SULFATE",
    "V V PEG SMEAR MEDIUM",
    "10MG ML CDK2 10% V V PEG3350",
    "10 - 15% W V PEG-3350",
    "MES MONOHYDRATE (PH: 6.0)",
    "SODIUM CITRATE:HCL",
    "THE 1.4 MM APO-PROTEIN WAS PREPARED IN 100 MM PH=5.6 NAOAC BUFFER. FOR EACH WELL",
    "HEPES (0.1M)",
    "GLYCIN-NAOH (",
    "PROTEIN WAS CONCENTRATED TO 30 MG ML IN 25 MM TRIS",
    "AMMONIUM SULFATE IN 0.1 M PHOSPHATE-CITRATE BUFFER",
    "PROTEIN CONCENTRATION 12 MG ML PROTEIN STOARAGE BUFFER: 10MM HEPES",
    "PEG 5000 MME",
    "MG(CL)2",
    "PROTEIN STOCK AT 45 MG ML IN THE REMARK 280 BUFFER OF 50 MM NAPO4 AND 500 MM NACL IS MIXED WITH THE REMARK 280 PRECIPITANT OF 0.2 M KSCN",
    "BIS-TRIS BUFFER (ADJUSTED TO",
    "22-25 % (W V) PEG 3350",
    "W V PEG 20",
    "CESIUM CHLORIDE",
    "POTASSIUM BROMIDE",
    "AMMONIUM SULPHATE 0.1 M TRISHCL",
    "MAGNESIUM CHLORIDE 0.1 M BICINE BUFFER",
    "AMMONIUM SULPHATE 0.1 M SODIUM CITRATE",
    "ATNAT9 WAS CONCENTRATED TO 15 MG ML AND INCUBATED WITH A THREEFOLD MOLAR EXCESS OF ACCOA FOR 18 H ON ICE. CRYSTALLIZATION DROPS CONTAINED 200 NL PROTEIN SOLUTION AND 200 NL PRECIPITANT SOLUTION (0.1 M HEPES (",
    "ATNATA229-226 WAS CONCENTRATED TO 10 MG ML AND INCUBATED WITH A FIVEFOLD MOLAR EXCESS OF COA FOR 18 H ON ICE. CRYSTALLIZATION DROPS CONTAINED 200 NL PROTEIN SOLUTION AND 200 NL PRECIPITANT SOLUTION. CRYSTALS APPEARED WITHIN 2-18 HOURS IN SEVERAL CONDITIONS. THE BEST DIFFRACTING CRYSTALS WERE OBTAINED FROM THE PRECIPITANT CONDITION WITH 0.1 M SODIUM CITRATE (",
    "PROTEIN STOCK SOLUTION OF 18.5 MG ML IN 20 MM HEPES",
    "SAMPLE: 22 MG ML JMJD5",
    "HEPES-NAOH (",
    "THE POTA:KARILYSIN COMPLEX AT 15 MG ML IN 50 MM SODIUM CHLORIDE",
    "TERT-BUTANOL",
    "THE POTC:MIROLASE COMPLEX AT 10 MG ML IN 2 MM CALCIUM CHLORIDE",
    "CALCIUM CHLORIDE HEXAHYDRATE",
    "TRI-POTASSIUM CITRATE",
    "POTASSIUM FORMATE",
    "ACETIC ACID",
    "PEG 4K 10 MM SODIUM CITRATE BUFFER",
    "PROTEIN IN 50 MM TRIS",
    "SODIUM FORMATE AND 20% (W V) PEG 3350",
    "PEPTIDE WAS MIXED IN A 3:1 RATIO WITH 0.1 M SODIUM ACETATE (",
    "PROTEIN 8MG ML",
    "SODIUM MALONATE DIBASIC MONOHYDRATE",
    "BUFFER SYSTEM 3 (1 M TRIS",
    "11-13 % PEG 8000",
    "BIS-TRIS PROPANE",
    "W V PEG3350",
    "PROTEIN SOLUTION: 5.7 MG ML PROTEIN IN 25 MM SODIUM PHOSPHATE",
    "PEG6000; 0.1M HEPES",
    "IMIDAZOL",
    "POTASSIUM SODIUM TARTRATE AND 19% PEG3350",
    "TTR:SB11 COMPLEX AT 5.2MG ML IN 10MM SODIUM PHOSPHATE",
    "TTR:SB14 COMPLEX AT 5.2MG ML IN 10MM SODIUM PHOSPHATE",
    "CADMIUM CHLORIDE HYDRATE",
    "W V POLY(ACRYLIC ACID SODIUM SALT) 5100 0.02 M MGCL2 0.1 M HEPES",
    "BUFFER FOR PROTEIN (150MM NACL",
    "COMMERCIAL SCREEN INDEX 44 (0.1 M HEPES",
    "SODIUM FORMATE 0.1 M HEPES",
    "PROTEIN INCUBATED WITH 5 MM UDP AND 1 MM PLP. PRECIPITANT: 18 - 22% POLY(ETHYLENE GLYCOL) 8000",
    "PROTEIN INCUBATED WITH 5 MM UDP-GLCNAC3NA AND 1 MM PLP. PRECIPITANT: 18 - 22% POLY(ETHYLENE GLYCOL) 8000",
    "PEG 20",
    "SAMPLE: 1.0 MM PHD2",
    "10-20 MG ML PROTEIN DISSOLVED IN 0.1 M SODIUM ACETATE",
    "PEG SMEAR LOW",
    "CTX-M-14 SOLUTION (22 MG ML) WAS MIXED WITH 45% PRECIPITANT SOLUTION (40% PEG8000",
    "2 MICROLITER OF THE BCL6-BTB WVIP COMPLEX AT 4 MG ML PLUS 1 MICROLITER OF A CRYSTALLISATION SOLUTION CONSISTING OF 1 M K2HPO4",
    "PEG3350 0.2M AMMONIUM ACETATE 0.1 M HEPES-NAOH",
    "PEG3350 0.1M HEPES-NAOH",
    "0.1 H HEPES-K",
    "TRIMETHYLAMINE N-OXIDE",
    "17-23% PEG 3350",
    "PEG6K AS PRECIPITANT IN",
    "HEPES (PH = 7.15)",
    "PROTEIN PRE-INCUBATED WITH 5.0 MM GDP",
    "7-14% PEG 10",
    "THE COMPOUND WAS DISSOLVED IN 100% DMSO TO 50 MM CONCENTRATION (2.30 MG + 86.2 UL DMSO). 15 UL GALECTIN-3C (20 MG ML IN 10 MM NA PHOSPHATE BUFFER",
    "50MM HEPES",
    "V V 1",
    "NA2HPO4",
    "HEPES-NAOH",
    "F33W CUBMB (1.0 MM) IN 100 MM TRIS",
    "NH4-SULFATE",
    "V V PEG SMEAR LOW",
    "PEG 3350 + 0.1M BIS-TRIS-METHANE:HCL",
    "28-35% PEG 4000 6000",
    "WELL NUMBER B2 CONDITIONS OF LMB SCREEN: 1.9M AMMONIUM SULPHATE",
    "CARBOXYLIC ACIDS (0.2M SODIUM FORMATE",
    "ZINC CHLORIDE",
    "MAGNESIUM CHLORIDE 0.1M TRIS HCL",
    "SITTING DROPS CONSISTED OF 0.19 UL A:0.19 UL B: A) 5.5 MG ML MPRO + 0.5 MM ML102 IN IN 20 MM TRIS",
    "MYABA.00170.A.B1.PS38577 AT 23.06 MG ML WITH 3.5 MM NAD AND 3.5 MM NITD-916 AGAINST THE INDEX SCREEN CONDITION H10: 0.2 M SODIUM CITRATE TRIBASIC",
    "POTASSIUM SODIUM TARTRATE TETRAHYDRATE",
    "SODIUM CITRATE TRIBASIC DIHYDRATE 0.1 M SODIUM HEPES",
    "ALCOHOLS (0.2 M 1",
    "HANGING-DROP VAPOR DIFFUSION USING EQUAL VOLUMES OF PROTEIN STOCK (3.9 MG ML) AND WELL RESERVOIR SOLUTION. CRYOPROTECTED IN 30% GLYCEROL. COMPLEX ON ICE AT 1:8 RATIO OF PR TO PI",
    "62 MG ML-1 PROTEIN MIXED 1:2 WITH COA-AC-LYS; DROPS (600 NL): 1:1 MIX OF (20 MM HEPES",
    "V V PEG 300",
    "V V GLYCEROL",
    "MES-NAOH",
    "CAPS",
    "PCTP BUFFER",
    "(NH4)2SO4 33% MPEG 2000 0.02M MERCAPTOETHANOL 0.1M PH=7.2 HEPES NAOH",
    "WIZARD 3 4 D11 (307537D11): 100 MM MES NAOH",
    "PROTEIN AT 8 MG ML IN 100 MM MES-BIS-TRIS",
    "AMMONIUM PHOSPHATE DIBASIC PH-8.0",
    "SODIUM ACETATE 0.2 M AMMONIUM SULFATE 16% PEG2000",
    "HEPES (4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID) 100 MM",
    "ACETATE",
    "36-41% PEG400",
    "PEG 6000 100 MM HEPES  SODIUM HYDROXIDE",
    "NAF",
    "ZINC ACETATE",
    "TRYPSIN 0.2 M KNO3 22 % (W V) PEG 3350) 14 DAYS",
    "11-17% REAGENT ALCOHOL",
    "SODIUM TARTRATE",
    "POTASSIUM CITRATE AND 20% W V PEG 3350",
    "W V PEG 3350",
    "1.6-2.0M SODIUM FORMATE",
    "RESERVOIR CONTAINED 1.1 M NACL",
    "RESERVOIR CONTAINED 1.0-1.1 M NACL",
    "TRIS-HCL; 250 MM SODIUM CHLORIDE; 12.9 % W V POLYETHYLENE GLYCOL 20",
    "OF CDK2 PROTEIN CRYSTALIZED IN 50MM SODIUM POTASSIUM PHOSPHATE",
    "TACSIMATE",
    "PEG1 000 200 MM MAGNESIUM CHLORIDE 100 MM SODIUM CACODYLATE",
    "25 W V% PEG 3350 0.1 M SODIUM ACETATE",
    "SODIUM ACETATE 0.2 M AMMONIUM SULFATE 15% PEG2000",
    "SODIUM ACETATE 0.2 M AMMONIUM SULFATE 20% PEG2000",
    "AMMONIUM SULFATE AND 0.1 M SODIUM CACODYLATE -",
    "W V PEG 4K",
    "THE PROTEIN WAS CRYSTALLIZED BY MIXING 0.45 UL OF 12 MG ML PROTEIN SOLUTION IN 10 MM HEPES",
    "SODIUM ACETATE HCL 3.5 M SODIUM FORMATE",
    "22-27% PEG4000",
    "19-22% PEG 4000",
    "PEG MME 2K; 0.1 M KSCN",
    "HAMPTON CRYSTAL SCREEN",
    "22-24% PEG 3000",
    "PRECIPITANT MIX: 1.4 M SODIUM MALONATE DIBASIC MONOHYDRATE PROTEIN BUFFER: 0.1 M CITRATE BUFFER",
    "THE MIXTURE OF PROTEIN SOLUTION AND AGAROSE WAS FILLED INTO A GLASS CAPILLARY",
    "TRIS8.0 30% W V POLYETHYLENE GLYCOL MONOMETHYL ETHER 2000",
    "TRIS8.0 28% W V POLYETHYLENE GLYCOL 4000",
    "50%-55% V V MPD",
    "POTASSIUMPHOSPHATE",
    "BIS-TRIS (ADJUSTED TO",
    "(+ -)-2-METHYL-2",
    "D-GLUCOSE",
    "SITTING DROP VAPOR DIFFUSION IN CRYSCHEM PLATES WITH RESERVOIRS OF 30% PEG 3350 BUFFERED AT",
    "4000",
    "MMT BUFFER",
    "SITTING DROP VAPOR DIFFUSION IN CRYSCHEM PLATES WITH 0.6 ML RESERVOIRS OF 30% PEG 3350 BUFFERED AT",
    "ADC-30 (5 MG ML) IN 24% W V POLYETHYLENE GLYCOL (PEG) 2000",
    "AMMONIUM NITRATE",
    "SODIUM CITRATE TRIBASIC DIHYDRATE",
    "POTASSIUM THIOCYNATE 0.1 M BIS_TRIS PROPANE 6.5 20% W V PEG 3350 1 MM PLP",
    "TRIS BICINE",
    "AMINO ACIDS(0.02 M DL-GLUTAMIC ACID MONOHYDRATE",
    "POTASSIUM THIOCYANATE",
    "2 UL OF 7 MG ML PROTEIN WITH 2 UL PRECIPITANT 1.9 M AMMONIUM SULFATE",
    "1:1 20-30 MG ML PROTEIN:3.8-4.0 M AMMONIUM SULFATE",
    "OF PRECIPITANT (35% PEG 2000 MME)",
    "BIS-TRIS PROPANE TRIS",
    "1 MICRO-LITER PROTEIN CONTAINING 3 MM BIOTIN IN 10 MM TRIS-HCL",
    "HEPES PH=7.1-7.7 0.19 M CACL2 5% GLYCEROL 24-29% PEG400",
    "20-25% PEG 3350",
    "COCRYSTALIZATION OF 12 MG ML PROTEIN",
    "POTASSIUM THIOCYANATE 0.1 M BIS-TRIS PROPANE 6.5 20 % W V PEG 3350 1 MM PLP",
    "V V POLYETHYLENE GLYCOL 400",
    "POTASSIUM PHOSPHATE (",
    "25-30% (W V) PEG3350",
    "PASI WAS CO-CRYSTALLIZED WITH FE(II) AND ALPHA-KETOGLUTARATE IN A HANGING DROP VAPOR DIFFUSION EXPERIMENT. THE PROTEIN SOLUTION [10 MG ML OF HIS-PASI",
    "PASI WAS CO-CRYSTALLIZED WITH VANADYL",
    "PROTEIN BUFFER: 20 MM TRIS HCL",
    "V V TACSIMATETM",
    "MAGNESIUM SULFATE HEPTAHYDRATE",
    "SODIUM ACETATE 17 % (W V) PEG3350",
    "SODIUM ACETATE 17 % (W V) PEG 3350",
    "8-13% (W V) POLYETHYLENE GLYCOL (PEG) 3350",
    "THE STOCK CONCENTRATION OF UBR1UBR FOR CO-CRYSTALLIZATION IS 7.52 MG ML. THE LIGAND TO PROTEIN MOLAR RATIO FOR UBR1UBR-RFF CO-CRYSTAL IS 1:2",
    "THE STOCK CONCENTRATION OF UBR2UBR FOR CO-CRYSTALLIZATION IS 6.2 MG ML. FOR UBR2UBR-RFF THE LIGAND TO PROTEIN MOLAR RATIO IS 1:2 AND THE RESERVOIRS CONTAIN 0.1 M BIS-TRIS",
    "THE STOCK CONCENTRATION OF UBR2UBR FOR CO-CRYSTALLIZATION IS 6.2 MG ML. FOR UBR2UBR-RYF THE LIGAND TO PROTEIN MOLAR RATIO IS 1:2 AND THE RESERVOIRS CONTAIN 0.1 M BIS-TRIS",
    "FOR UBR2UBR-RWF CO-CRYSTAL",
    "150 MMOL L DL-MALATE DISSODIC",
    "MORPHEUS 0.09M HALOGENS",
    "MORPHEUS 0.09 M HALOGENS",
    "AMMONIUM SULFATE 28% PEG MME 2000 0.1 M SODIUM ACETATE",
    "MES MONOHYDRATE (",
    "POTASSIUM SODIUM TARTRATE TETRAHYDRATE (",
    "PEG 80000",
    "HEPES BUFFER 25%PEG3350",
    "PROTEIN BUFFER: 20MM TRIS HCL",
    "TRISHCL (",
    "HEPES-K",
    "AMMONIUM SULFATE AND 0.1M HEPES PH: 7.0",
    "AMMONIUM SULFATE AND 0.1M TRIS PH: 6.5",
    "AMMONIUM SULFATE AND 0.1M TRIS PH: 6.7",
    "AMMONIUM SULFATE AND 0.1M BIS-TRIS",
    "10-14% V V PEG300",
    "ORIGINAL CRYSTAL: 47.5 MICROLITER CK2ALPHAPRIME MIXED WITH 2.5 MICROLITER OF A 20 MM CX-4945 SOLUTION IN DMSO TO A FINAL CONCENTRATION OF 5 MG PER ML PROTEIN AND 1 MM CX-4945. RESERVOIR (900 MM LICL",
    "MOLECULAR DIMENSIONS; 0.09 M HALOGENS",
    "0.15-0.2 M (NH4)3-CITRATE 21-23% PEG 3350",
    "18-23% PEG3350 + 0.11-0.2M NACL + 0.10M BIS TRIS",
    "22-27% PEG3350 + 0.11-0.20M NACL + 0.10M MES",
    "PEG 3350 + 0.20M SODIUM CHLORIDE + 0.10M MES",
    "MES 5.5",
    "POTASSIUM DIHYDROGEN PHOSPHATE",
    "MES 6 PH",
    "FOSAKP IN 10 MM HEPES",
    "SODIUM HEPES AND MOPS",
    "PEG 1000 0.2 M NAH2PO4",
    "CRYSTALS WERE PRODUCED ON A JUNIOR CLOVER PLATE USING A CRYSTALLIZATION SOLUTION CONTAINING 20 % W V POLYETHYLENE GLYCOL 3",
    "W V PEG 2000",
    "AMMONIUM CITRATE DIBASIC 20% W V PEG 3350 (JCSG+ CRYSTALLIZATION SCREEN; MOLECULAR DIMENSIONS LTD.",
    "NACIT",
    "MALONATE",
    "A CO-CRYSTAL WITH LACTOSE",
    "MES: NAOH",
    "AMMONIUM CHLORIDE 20% W VPEG 3350 1 MM OCTA-N-ACETYL-CHITOOCTAOSE",
    "AMMONIUM CITRATE DIBASIC 20% W V POLYETHYELE GLYCOL 3350",
    "OF SODIUM CITRATE",
    "BERKELEY F12: 35% MPD",
    "CRYSTALLISATION WAS CARRIED OUT ON A JUNIOR CLOVER PLATE USING A SOLUTION CONTAINING 20% W V POLYETHYLENE GLYCOL 3",
    "2 UL PROTEIN AT 24.6 G L IN 25 MM TRIS HCL",
    "OF SODIUM CITRATE 50MM TRIS-HCL",
    "PROTEIN: 7.0 MG ML",
    "14-3-3SIGMA DELTA C",
    "MORPHEUS BUFFER 2 (PH: 7.5): 0.10M - MORPHEUS ETHYLENE GLYCOLS: 21.50%W V MORPHEUS AMINO ACIDS: 0.11M",
    "MORPHEUS BUFFER 2 (PH: 7.5): 0.10M - MORPHEUS ETHYLENE GLYCOLS: 32.00%W V MORPHEUS AMINO ACIDS: 0.11M",
    "0.1 MOL L KBR",
    "PEG 8000 AND 0.1 M OF HEPES",
    "PEG 8000 AND 0.1M HEPES",
    "W V PEG 20K",
    "PEG 1500 AND 0.1 M SPG BUFFER",
    "NH4SO4",
    "AMMONIUMCITRATE PROTEIN CONCENTRATION: 6.8 MG ML 25 MM NA-PHOSPHATE BUFFER",
    "ALCOHOLS",
    "SODIUM BICINE",
    "SODIUM BICINE (",
    "20%W VPOLYETHYLENEGLYCOL 3",
    "PEG 6000 30% BIS-TRIS PROPONE",
    "HEN EGG WHITE LYSOZYME (100MG ML)",
    "JSCG+ CONDITION F16: 0.1 M HEPES",
    "AMMONIUM SULFATE; 0.1M SODIUM ACETATE",
    "W V PEG 20 000",
    "TRIS-ACOH",
    "TRIS 50 MM SODIUM CITRATE 100 MM",
    "PROTEIN SOLUTION: 90 MIKROLITER CK2ALPHA'-CYS336SER SOLUTION (5 MG ML IN 500 MMOL L NACL",
    "22",
    "PROTEIN CONCENTRATION WAS 18 MG ML; STORAGE BUFFER: 20MM TRIS",
    "8 %V V 1-PROPAN 0.1 M MES",
    "PROTEIN AT 5 MG ML IN 100 MM AMMONIUMACETATE",
    "AMMONIUM CITRATE DIBASIC; 20% W V PEG 3350",
    "ACETATE BUFFER",
    "1.55-1.6 M SODIUM CITRATE",
    "SODIUM CITRATE OR 30% PEG4000",
    "CRYSTALLIZATION: 5 MG ML PROTEIN",
    "METHANOL (IN SITTING DROP); 59% METHANOL",
    "15-25% PEG 3350",
    "4.93 MG ML",
    "PROTEIN: 4.93 MG ML",
    "0.05 SODIUM CACODYLATE TRIHYDRATE",
    "SODIUM ACETATE 0.1M AT",
    "HEPES PH=7.5 1.4 M SODIUM CITRATE TRIBASIC DIHYDRATE PROTEIN CONCENTRATION= 7. 6MG ML SOAKING WITH HGCL2 OVER NIGHT",
    "LISO4 100 MM NA ACETATE 24-30% PEG 6000",
    "PEG 6.000",
    "IMIDAZOLE MES BUFFER",
    "SODIUM SUCCINATE",
    "BIS-TRIS: HCL",
    "14-18% PEG8000",
    "V V POLYETHYLENE GLYCOL 200",
    "BIS-TRIS-PROPANE",
    "SODIUM THIOCYANATE AND 20% PEG 3350",
    "PROTEIN STOCK SOLUTION: 5 MG ML PROTEIN",
    "MORPHEUS 50 % PRECIPITANT MIX 1",
    "1. CRYO BUFFER: 80 UL TRIM21 (RESERVOIR SOLUTION: 0.1 M CIRTIC",
    "JEFFAMINE ED-2001",
    "BERKELEY F12: 25% MPD",
    "NA-CITRATE (",
    "18 - 23 % PEG3350",
    "PROTEIN SOLUTION: 10.3 MG ML IN 50 MM TRIS HCL",
    "THE PROTEIN SOLUTION CONTAINED 16 MG ML PROTEIN IN 20 MM HEPES",
    "0.24 AMMONIUM FORMATE AND 35% PEG3350",
    "PROPLEX B8: 15% W V PEG 4000",
    "INDEX HT C6: 1.5M AMMONIUM SUFATE",
    "12-20% PEG4000",
    "CALCIUM CHLORIDE DIHYDRATE 24% V V POLYETHYLENE GLYCOL 400 40MM BARIUM CHLORIDE",
    "BICINE 2.0 M MAGNESIUM CHLORIDE 100 MM SODIUM CHLORIDE 60 MM FERROUS CHLORIDE 3 MM SODIUM AZIDE",
    "BICINE 2 M MAGNESIUM CHLORIDE 100 MM SODIUM CHLORIDE 60 MM FERROUS CHLORIDE 3 MM SODIUM AZIDE",
    "PEG MONOMETHYL ETHER",
    "THAWED AGBR1 PROTEIN WAS DESALTED WITH 150 MM NACL",
    "MIB",
    "DI-AMMONIUM HYDROGEN PHOSPHATE",
    "100 MES TRIS",
    "AMMONIUM CHLORIDE 0.2 M AND PEG 3350 20%.",
    "AMMONIUM CHLORIDE 0.2 M AND PEG 3350 20%",
    "POTASSIUM SODIUM TARTRATE TETRAHYDRATE; 0.1 M BIS-TRIS PROPANE",
    "AMMONIUM PHOSPHATE BUFFER",
    "POTASSIUM PHOSPHATE (DIBASIC) 0.8M SODIUM PHOSPHATE (MONOBASIC)",
    "BISTRIS 200 MM MGCL2 20% PEG 3350",
    "PROTEIN SOLUTION: 2.6 MG ML P53 DBD-DARPIN C10-H82R COMPLEX IN 50 MM HEPES",
    "PRECIPITANT: 25.5% (W V) PEG 4000",
    "PRECIPITANT: 19% (W V) PEG 4000",
    "20-25% PEG8000",
    "MOPS",
    "AMMONIUM ACETATE 16% PEG 3",
    "MIB BUFFER",
    "HEXAFLUOROISOPROPANOL IN WATER",
    "PROTEIN BUFFER: 10 MM TRIS-HCL",
    "V V PEG 3350",
    "AMMONIUM CITRATE",
    "PEG8000 AND 100 MM MES BUFFER (",
    "BIS-TRIS PH=6.5",
    "PROTEIN: 6.6 MG ML",
    "ISOPROPANOL IN WATER",
    "NA ACETATE",
    "32-35%(V V) POLYETHYLENE GLYCOL 3350",
    "PROTEIN BUFFER: 20 MM TRIS-HCL (",
    "POTASSIUM PHOSPHATE DIBASIC",
    "VPS4 MIT DOMAIN (10MG ML) IN 20MM TRIS PH = 8",
    "PROTEIN BUFFER: 20 MM TRIS",
    "PROTEIN WAS CONCENTRATED TO 8 MG ML IN 20 MM POTASSIUM PHOSPHATE",
    "DROPS CONSISTED OF 2 UL GALECTIN-8N AT 13.1 MG ML IN PBS BUFFER",
    "POTASSIUM FLUORIDE",
    "SODIUM CHLORIDE 0.1 M SODIUM CITRATE",
    "SAMPLE OF HUMAN CHYMASE IN 50 MM MES NAOH",
    "LISO4 (SALT)",
    "HDAC6 PROTEIN PRECIPITATE CONDITION",
    "[V V] PEG 3",
    "6%PROPANOL",
    "PEG5000",
    "BIS TRIS PROPANE",
    "(10-35%) PEG 4K",
    "TRI-SODIUM CITRATE DIHYDRATE",
    "PEG 4K 10 % (V V) 2-PROPOH 0.1 M HEPES",
    "CONCENTRATED PROTEIN IN 0.5 MM EDTA",
    "PROTEIN IN 0.5 MM NA-EDTA",
    "PEG 3350 AND 0.2 M MAGNESIUM SULFATE",
    "MGCL2 6 H2O",
    "MORPHEUS SCREEN SOLUTION: 0.1 M SODIUM HEPES MOPS (ACID) BUFFER SYSTEM (",
    "SODIUM MALONATE DIBASIC MONOHYDRATE 20% (W V) PEG 3350",
    "BIS-TRIS BUFFER AT",
    "\"TACSIMATE\"",
    "BIS-TRIS BUFFER",
    "MONOSACCHARIDES",
    "41-46% 2-METHYL-2",
    "DI-AMMONIUM TARTRATE",
    "POLYETHYLENE GLYCOL 8K",
    "AMMONIUM SULFATE 0.1 M BIS-TRIS",
    "NA K PHOSPHATE BUFFER",
    "W V PEG 1500",
    "JCSG+ B5: 40% (V V) MPD",
    "A SOLUTION CONTAINING DNA 1.8 MM",
    "MAGNESIUM CHLORIDE HEXAHYDRATE 0.1 M SODIUM HEPES 7.5 30 % V V PEG 400",
    "SODIUM POTASSIUM TARTRATE",
    "W V PEG 8000 0.1M MES 6.0 0.24M AMMONIUM SULFATE",
    "AMMONIUM CHLORIDE",
    "A SOLUTION CONTAINING 0.6 MM DNA",
    "MICROSEEDING OF PBFUCA-1 0.12 M ETHYLENE GLYCOLS",
    "GLYCINE AT",
    "THE ENZYME (8.6 MG ML) IN 50 MM HEPES",
    "CA ACETATE",
    "ZN ACETATE",
    "(5MG ML) HCGAS CATALYTIC DOMAIN WAS MIXED WITH 17 16 BP DSDNA IN A MOLAR RATIO OF 1:1.25 PROTEIN:DNA IN A BUFFER CONTAINING 20 MM TRIS",
    "PRECIPITANTS AGENTS (25% (V V) MPD",
    "PROTEIN SOLUTION WAS MIXED 1:1 WITH AN OPTIMIZED SOLUTION CONSISTING OF 100 MM",
    "0.17 NAOAC",
    "D12 JCSG++ (JENA BIOSCIENCE); 40 MM KH2PO4",
    "B11 PROPLEX (MOLECULAR DIMENSIONS); 0.1 M HEPES",
    "INDEX D8: 0.1M HEPES",
    "PROTEIN IN 20MM BICINE NAOH",
    "THE PROTEIN WAS SET UP IN MRC2 PLATES IN 100 NL PLUS 100 NL DROPS WITH THE PROTEIN AT 5 MG ML WITH RESERVOIR SOLUTIONS BEING 2.6 TO 2.9 M AMMONIUM SULFATE AND 100 MM TRIS BUFFER AT",
    "THE PROTEIN WAS SET UP IN MRC-2 PLATES (MOLECULAR DIMENSIONS",
    "W V PEG3000",
    "POLYETHYLENE GLYCOL 4000",
    "SODIUM FLUORIDE",
    "V V PEG400",
    "PROTEIN:LIGAND COMPLEX AT ~4MG ML IN 20 MM HEPES",
    "JCSG+ C1: 20% (W V) PEG 8000",
    "JCSG+ B6: 0.1 M POTASSIUM PHOSPHATE CITRATE",
    "MORPHEUS F4: 12.5%(V V) MPD",
    "CRYSTAL SCREEN HT A10: 0.20 M AMMOUNIUM ACETATE",
    "MORPHEUS H8: 12.5%(V V) MPD",
    "AMMONIUM SULFATE DIBASIC",
    "POLYETHYLENE GLYCOL 3350",
    "SODIUM CHLORIDE 19% POLYETHYLENE GLYCOL 3350",
    "NH4-ACOH",
    "SODIUM ACETATE TRIBASIC",
    "DROP CONTAINING 2.0 &#956;L OF 1:1 (V V) MIXTURE OF PROTEIN SOLUTION (10 MG ML",
    "PEG6000. 0.1 M HEPES",
    "CA9 MIMIC CRYSTALS WERE OBTAINED IN SITTING DROP PLATES WITH SEEDING. THE PROTEIN CONCENTRATION WAS ABOUT 5.5 MG ML",
    "RESERVOIR CONTAINED 0.1 M HEPES",
    "FREE-INTERFACE DIFFUSION OF A 10 UL OF 30 MG ML PROTEIN SOLUTION",
    "NAFORMATE",
    "PEG1500 +20% GLYCEROL",
    "PEG 3000",
    "1.6-2.5 M SODIUM ACETATE AND 0.1 M SODIUM CITRATE",
    "AMMONIUM SULFATE AND 0.1 M SODIUM ACETATE (",
    "V V PEG-4000 100 MM HEPES  SODIUM HYDROXIDE",
    "20 %W V POLYETHYLENE GLYCOL 3350",
    "PACT SCREEN FROM MOLECULAR DIMENSIONS CONDITION F2 (20 % PEG 3350",
    "K2SO4 AND 20% (W V) PEG 3350",
    "PEG 3350 38%",
    "PEG MME 2000; 0.15 M AMMONIUM SULFATE; 0.1 M SODIUM ACETATE",
    "PEG 8K",
    "SIRT3 (118-399) (10.3 MG ML) WAS CRYSTALLIZED IN COMPLEX WITH FDL (QPKKAC-7-AMINO-4-METHYLCOUMARIN) PEPTIDE (3 MM) AND HONOKIOL (1 MM) IN 25% PEG 3350",
    "PROPLEX D9: 15% (W V) PEG 6000",
    "PROPLEX C3: 20% (W V) PEG 4000",
    "SODIUM TARTRATE DIBASIC DIHYDRATE",
    "MORPHEUS E4 (12.5% W V PEG 1000",
    "SODIUM CITRATE TRIBASIC IN 0.1 M HEPES AT",
    "PEG-3350",
    "PCB: 0.100000 M PH:6.00 ; PEG 1500: 25.000000 %W V",
    "NA K TARTRATE",
    "0.05 - 0.2 M SODIUM FORMATE",
    "MOLECULAR DIMENSIONS MORPHEUS SCREEN CONDITION THAT INCLUDED 100 MM NAHEPES MOPS",
    "AMMONIUM PHOSPHATE",
    "PEG 6.000 10% ETHYLENE GLYCOL 0.2 AMMONIUM CHLORID",
    "AMMONIUM SULFATE 0.2M SODIUM POTASSIUM TARTRATE",
    "AMMONIUM SULFATE.",
    "NA-BICINE",
    "DIFFRACTION QUALITY CRYSTALS WERE EVENTUALLY OBTAINED BY SITTING DROP VAPOR DIFFUSION BY MIXING 2 UL OF RNA WITH 2 UL OF CRYSTALLIZATION REAGENT CONTAINING 200 MM NACL",
    "2-16% PEG 1000 AND 0.1M CITRIC ACID AT",
    "POTASSIUM PHOSPHATE MONOBASIC AND 18% PEG 3350",
    "POTASSIUM PHOSPHATE MONOBASIC AND 18% PEG 3350. FOR REDUCTION CRYSTALS ARE SOAKED IN SODIUM DITHIONITE SOLUTION",
    "SODIUM MALONATE DIBASIC MONOHYDRATE 0.1M HEPES",
    "ZINC SULFATE 100 MM MES",
    "ZINC SULFATE 25% PEG 550-MME 100 MM MES",
    "NAACETATE",
    "PROTEIN: 8.4 MG ML",
    "W V PEG 8000",
    "P3350",
    "CRYSTALLIZATION SOLUTION: OF 20% W V PEG 3350",
    "HANGING DROP VAPOR DIFFUSION AGAINST 0.1 M PHOSPHATE BUFFER",
    "PROTEIN MIXED WITH 10:1 MOLAR RATIO OF D-MANNOSE TO PROTEIN. CRYSTALS GROWN IN 0.4 M MGCL2",
    "W V PEG MME 2000",
    "GLYCEROL",
    "AMINO ACIDS",
    "CRYSTALLIZATION BUFFER: 0.025MM NICL2 10 MM MGCL2 2.5% MPD 25 MM NACACO",
    "NH4CL",
    "AMMONIUM TARTRATE DIBASIC",
    "SODIUM MALONATE; 0.1 M BIS TRIS PROPANE",
    "ZNSO4",
    "3-MORPHOLINOPROPANE-1-SULFONIC ACID (MOPS)",
    "PIPES",
    "HDAC6",
    "PROTEIN SOLUTION:10 MG ML IN 25 MM HEPES",
    "PEG 3350 PEG 1K MPD (1:1:1) 37.5%",
    "SODIUM CITRATE (",
    "WELL SOLUTION: 2.1 M DL-MALIC ACID",
    "26-28% W V JEFFAMINE ED-2001",
    "CRYSTAL GROWN: 6.0 M AMMONIUM NITRATE",
    "CATHEPSIN S (7 MG ML) WAS MIXED WITH AN EQUAL VOLUME OF RESERVOIR AND EQUILIBRATED AGAINST 20% (W V) PEG4000",
    "SODIUM ACETATE 50 % V V POLYETHYLENE GLYCOL 400 200 MM LITHIUM SULFATE",
    "LISO4 (SALT) 0.1 M NA ACET 4.5 PH (BUFFER) 25 %W V PEG 8K (PRECIPITANT)",
    "ISOPROPANOL",
    "AMMONIUM SULFATE AND 0.1 M BIS-TRIS",
    "IMIDAZOLE MES (",
    "10-35% PEG 4K",
    "5 %V V PEGSB",
    "22.5 %V V PEGSB",
    "18.182 %V V PEGSH 0.1 M BICINE 9.16 PH",
    "HEPES; 0.2 M NACL; 25% PEG 3350",
    "SODIUM MALONATE; 20% PEF 3350",
    "PEG3000 0.1M CITRATE",
    "CRYSTAL-C7:0.2M (NH4)2SO4",
    "CRYSTAL-C4:0.2M NAAC",
    "INDEX-D5:0.1M NAAC",
    "PEG5000 MME",
    "W V PEG 10000 0.1M HEPES",
    "0.2MSODIUM CHLORIDE 0.1M MES",
    "26-30.5% ETHYLENE GLYCOL",
    "W V POLYETHYLENE GLYCOL MONOMETHYL ETHER 2",
    "BPGM-D10N",
    "26-33% PENTAERYTHRITOL ETHOXYLATE (15 4 EO OH) AKA PEE-797",
    "PEG 550MME",
    "INDEX-H6 (0.2M SODIUM FORMATE",
    "2.5-2.8 M AMMONIUM SULFATE",
    "PEG MME550; 0.1M TRIS",
    "COBALT CHLORIDE",
    "NA CACODYLATE",
    "AMMONIUM SULFATE WITH 50 MM HEPES BUFFER (",
    "1:2 LYSOZYME (100 MG ML-1 IN 50 MM NAOAC (",
    "MAGNESIUM NITRATE HEXAHYDRATE",
    "LITHIUM NITRATE",
    "CRYSTALS WERE FOUND IN 20% PEG3350 WITH 200 MM SODIUM DIHYDROGEN PHOSPHATE WHEN SET UP IN SITTING DROP PLATES WITH 200 NL RESERVOIR AND 200 NL OF 12 MG ML PROTEIN IN SD-2 PLATES AT ROOM TEMPERATURE.",
    "SODIUM FORMATE AND 10 % GLYCEROL",
    "0.2 UL 11 MG ML MIF (100 MM TRIS-HCL",
    "ENDOTHIAPEPSIN IN 0.1 M SODIUM ACETATE AT",
    "PEG 8K 0.2M MGACETATE 0.1 SODIUM CACODILATE",
    "13UL 10MG ML FPHH (10MM HEPES",
    "0.04-0.24 M AMINO ACIDS",
    "K-ACETATE",
    "W V PEG 20000",
    "AMMONIUM PHOSPHATE 0.1M TRISHCL",
    "MPEG 2K",
    "SHOTGUN1 WELL A01 0.2M MAGNESIUM CHLORIDE HEXAHYDRATE",
    "SHOTGUN1 ECO 0.2 MAGNESIUM CHLORIDE HEXAHYDRATE 0.1 M TRIS",
    "THE PROTEIN IN COMPLEX WITH GABA WAS CRYSTALLIZED IN DROPS CONTAINING 1 UL PROTEIN SOLUTION (60 MG ML PROTEIN IN BUFFER CONTAINING 10 MM HEPES",
    "THE PROTEIN IN COMPLEX WITH L-PROLINE WAS CRYSTALLIZED IN DROPS CONTAINING 1 UL PROTEIN SOLUTION (60 MG ML PROTEIN IN BUFFER CONTAINING 10 MM HEPES",
    "THE PROTEIN WAS CRYSTALLIZED IN DROPS CONTAINING 1 UL PROTEIN SOLUTION (60 MG ML PROTEIN IN BUFFER CONTAINING 10 MM HEPES",
    "THE PROTEIN IN COMPLEX WITH DMSP WAS CRYSTALLIZED IN DROPS CONTAINING 1 UL PROTEIN SOLUTION (60 MG ML PROTEIN IN BUFFER CONTAINING 10 MM HEPES",
    "PEG-8000",
    "PHOSPHATE CITRATE PH=4.2 40 % PEG 300 DIRECTLY FROM CRYSTALLIZATION SCREEN",
    "WELL SOLUTION COMPRISING 20-30% PEG300",
    "SPERMINE",
    "RESERVOIR CONTAINED 0.2 M SODIUM FORMATE AND 20% (W V) PEG 3350. ENZYME SOLUTION CONTAINED 20 MM 1-HYDROXYETHANE-1-SULFONATE. CRYSTAL WAS SOAKED IN CRYOBUFFER CONTAINING 20% PEG 200 AND 20 MM 1-HYDROXYETHANE-1-SULFONATE",
    "4%V V TACSIMATETM",
    "8-12% (W V) POLY(ETHYLENE GLYCOL) 8000",
    "PROTEIN INCUBATED WITH 5.0 MM UDP-4-AMINO-2",
    "NAACETATE PH=4.8",
    "KSCN 25% PEG 3350",
    "F4 .1M KSCN 25% PEG 3350",
    "KSCN 28% PEG 3350",
    "POLYETHYLENE GLYCOL 2000",
    "AMMONIUM PHOSPHATE 0.1M TRIS HCL",
    "HEPES MOPS [",
    "BICINE TRIZMA BASE",
    "P2000 MME",
    "INDEX-E7 (0.05M MGCL2",
    "INDEX-F11 (0.2M NACL",
    "PROTEIN SOLUTION: 5.5-6.0 MG ML IN 25 MM HEPES (",
    "PROTEIN SOLUTION: 5.5-6.0 MG ML IN 25 MM PHOSPHATE (",
    "THE CRYSTALLISATION CONDITION USED IS INDEX 71 (CAT. NO.: HR2-944-71; HAMPTON RESEARCH",
    "BICINE 10% V V MPD",
    "TMAO 0.1 M TRIS (",
    "AMMONIUM ACETATE 0.1 M BIS-TRIS (",
    "MAGNESIUM FORMATE DIHYDRATE 20% W V PEG 3350",
    "SODIUM NITRATE 0.1 M BIS-TRIS PROPANE (",
    "PEG 8000 0.6 M NACL 0.1 M IMIDAZOLE MALATE PROTEIN CONCENTRATION: 14 MG ML",
    "PRECIPITANT: 0.1 M CITRIC ACID (",
    "POTASSIUM CITRATE 18% PEG 3350",
    "PEG6000 -- 10% ETHYLENE GLYCOL -- 0.1M MES",
    "20-24% PEG8K",
    "100 MM SODIUM ACETATE",
    "PROPLEX D5: 8% (W V) PEG 6",
    "PEG 3000 0.1M SODIUM CITRATE",
    "TBG (TARTRATE",
    "MMT (L-MALIC ACID",
    "PHOSPHO-CITRATE BUFFER",
    "SODIUM FORMATE AND 200 MM NDSB-201",
    "THE PURIFIED KEAP1 KELCH DOMAIN WAS CONCENTRATED TO 6-10 MG ML AND CRYSTALLIZED WITH THE SOLUTION CONTAINING 0.1 M NA ACETATE (",
    "CHES (",
    "PEG 8000 IN 0.2M CALCIUM ACETATE HYDRATE AND 0.1M SODIUM CACODYLATE TRIHYDRATE",
    "N-(2-ACETANIDO) IMINODIACETIC ACID",
    "CACODYLATE",
    "NAH2PO4 1.24 M K2HPO4 100 MM NA-ACETATE AT",
    "PEG 8000 30% AMMONIUM ACETATE 0.6 M SODIUM ACETATE 0.065 M",
    "1 UL PROTEIN (21.6 MG ML IN 20 MM TRIS-HCL",
    "LITHIUM ACETATE",
    "MAGNESIUM CHLORIDE HEXAHYDRATE 20 % W V PEG 3350",
    "NA CITRATE",
    "SODIUM FLUORIDE; 0.03M SODIUM BROMIDE; 0.03M SODIUM IODIDE",
    "PEG 6000 50%W V HEPES 0.1M DMSO 5%",
    "PEG600 0.1M HEPES",
    "PEG8000 0.1 M HEPES",
    "MPD 0.1 M HEPES",
    "50 MM AMMONIUM N-[TRIS(HYDROXYMETHYL) METHYL]-2-AMINOETHANE SULFONATE",
    "MORPHEUS SCREEN CONDITION A2 (0.06 M MAGNESIUM CHLORIDE",
    "LITHIUM SULFATE; 0.1 M SODIUM HEPES 7.5",
    "ELUTION BUFFER (SIZE EXCLUSION): 50 MM HEPES",
    "50 MM AMMONIUM N-[TRIS(HYDROXYMETHYL)METHYL]-2-AMINOETHANE SULFONATE",
    "LATENT ENZYME",
    "ENZYME",
    "15 MG ML",
    "MORPHEUS SCREEN ETHYLENE GLYCOLS 0.1 M MORPHEUS SCREEN BUFFER SYSTEM 3",
    "TACSIMATE; 17% PEG3350; 10% SUCROSE.",
    "NA-CITRATE",
    "2MICROLITRES OF 15MG ML PROTEIN IN 20MM TRIS BUFFER",
    "HEPES SODIUM 1 M MONOHYDRATE LITHIUM SULFATE",
    "PEG 8000 0.1M TRIS PH=7.5",
    "CRYSTALLIZATION BUFFER: 0.1M AMMONIUM CITRATE (",
    "CRYSTALLIZATION BUFFER: 0.1M SODIUM BICINE (",
    "SODIUM MALONATE AND 1% GLYCEROL",
    "PRECIPITANT: 23% W V PEG 3350",
    "PRECIPITANT:27% W V PEG 3350",
    "NACITRATE",
    "W V PEG5000 MME",
    "PROTEIN CONCENTRATION 26MG ML IN HEPES 10MM",
    "CAPS-NAOH",
    "AMINO ACIDS II",
    "CARBOXYLIC ACID",
    "PENTAERYTHRITOL ETHOXYLATE 15 4",
    "15-20% (W V) PEG 3350",
    "0.2-0.4M AMMONIUM CHLORIDE",
    "18-22% PEG 8000",
    "MORPHEUS 0.09M NPS",
    "CRYSTALLIZED IN: 23-27% PEG3350",
    "PEG-MME 2000",
    "SODIUM SUCCINAT",
    "HEPES HCL",
    "0.5 UL 64 MG ML EFE-Y306A (1 MM MANGANESE CHLORIDE",
    "DL-MALIC ACID AND 20% PEG3350",
    "PEG 3350 + 0.05 M SODIUM ACETATE",
    "0.5 UL 64 MG ML EFE (1 MM MANGANESE CHLORIDE",
    "PEG 3350 0.17M KCL 3% D-(+) TREHALOSE DIHYDRATE",
    "AMMONIUM FORMATE 20% PEG 3350",
    "PEG 1500 25 % SODIUM CHLORIDE 0.2 M SODIUM CACODYLATE 0.1 M",
    "MMT 25% PEG 1500",
    "PACT PREMIER A01: 0.1 M SPG BUFFER",
    "PACT PREMIER A04: 0.1 M SPG",
    "NAH2PO4",
    "MES: 45% DMSO: 0.7-0.9 M NACL: 0-0.4 M CDCL2: RESERVOIR SOLUTION CONTAINING 30-40% AMMONIUM SULPHATE",
    "0.6-0.8 M (NH4)2SO4",
    "0.05 CALCIUM CHLORIDE 0.1M BIS-TRIS",
    "MGCL2 0.1M TRIS HCL",
    "BATCH MICROCRYSTALS WERE PREPARED BY RAPIDLY MIXING 20 MG ML ACNIR IN 20MM TRIS",
    "NACACODYLATE",
    "KH2PO4 + 3.0 M K2HPO4 (2:1)",
    "2-ETHANESULFONIC ACID",
    "DS DNA CONTAINING 5 MM ZINC ACETATE",
    "A CRYSTAL WAS GROWN BY MIXING 1 UL OF RESERVOIR BUFFER (2 M AMMONIUM SULFATE",
    "PEG 1000 100MM NATRIS-HCL",
    "NACL 0.1M HEPES",
    "HANGING DROP VAPOUR DIFFUSION: 28% (W V) PEG 4000",
    "MES BUFFER",
    "W V POLYETHYLENE GLYCOL 1500",
    "MALATE-IMIDAZOLE BUFFER",
    "DNA",
    "PROTEIN: 11.0 MG ML",
    "AMMONIUM SULFATE AND 0.25 M POTASSIUM FORMATE",
    "PROTEIN WORKING STOCK WAS PREPARED FROM 2:1 V V MIXING OF 30MG ML PROTEIN IN 20MM TRIS",
    "SITTING DROP OF FINAL VOLUME OF 0.8 UL WAS SET UP BY 1:1 V V MIXING OF 15 MG ML E. COLI DHFR WORKING STOCK WITH RESERVOIR SOLUTION CONTAINING 0.1M MES",
    "1:1 V V MIXING RATIO OF 30 MG ML OF PURIFIED E. COLI DHFR IN 20MM TRIS",
    "TRIS BUFFER (",
    "POLYETHYLENE GLYCOL 4",
    "PROTEIN WAS CONCENTRATED TO 6 MG ML IN A STORAGE BUFFER CONSISTING OF 20 MM TRIS-HCL AT",
    "10UL OF 50MM 3-AMINOPHENOL WAS DEPOSITED ON A COVER SLIP AND ALLOWED TO DRY. A 20 UL PELLET OF 4% SODIUM CHLORIDE + 5% ETHYLENE GLYCOL + 10% GLYCEROL IN 2% AGAR WAS DEPOSITED ON THE COVER SLIP. ADJACENT TO THIS WAS POSITIONED LYSOZYME (10 UL OF 30 MG ML LYSOZYME IN 100 MM SODIUM ACETATE",
    "MGCL2.6H2O",
    "(W V) PEG 1500",
    "GAL3C IN 10 MM SODIUM PHOSPHATE BUFFER",
    "A 20 UL PELLET OF 50 MM CADMIUM SULFATE IN 2% AGAR WAS DEPOSITED ON A COVER SLIP. ADJACENT TO THIS WAS POSITIONED FERRITIN (10 UL OF 50 MG ML FERRITIN",
    "33.0 V V PEG 400 0.1 M TRIS HYDROCHLORIDE",
    "PROTEIN IN 10 MM HEPES (",
    "TRISHCL",
    "AMMONIUM SULFATE AND 0.1 M NA-ACETATE",
    "PEG3",
    "DROP WAS A 1:1 MIX OF PROTEIN (10 MG ML IN 10 MM TRIS-CL",
    "AMMONIUM SULPHATE AND 0.1 M BIS-TRIS PROPANE",
    "PROTEIN IN 20MM HEPES NAOH",
    "PEG 6K 10.0 % ETGLY 0.1 M HEPES",
    "PEG3350 10.0 % ETGLY 0.2 M NACHO",
    "PEG 1K 0.1M SPG",
    "PEG3350 10.0 % ETGLY 0.1 M BIS-TRIS-PROPANE",
    "PROTEIN SOLUTION: 10 MG ML PROT.",
    "TRIS:HCL BUFFER",
    "1.2-2.2 M AMMONIUM SULPHATE",
    "SODIUM FORMATE 4.0 M",
    "1.2-1.35 M (NH4)2SO4",
    "AMMONIUM NITRATE 20% PEG 3350 0.1 M BETAINE MONOHYDRATE (AS AN ADDITIVE)",
    "150 TO 225 MM POTASSIUM ACETATE AND 20% TO 27.5% POLYETHYLENE GLYCOL 3350.",
    "0",
    "14-20% PEG 3350",
    "IN 0.1 M TRIS BASE (",
    "TRIS BASE (",
    "MYGEA.00966.A.B1.PW38486 AT 15.59 MG ML WAS INCUBATED WITH 5 MM RIBOSE-5-PHOSPHATE",
    "POLYETHYLENE GLYCOL 6000",
    "V V PROPANOL",
    "PHOSPHATE BUFFER",
    "BIS-TRIS:HCL BUFFER",
    "DI-AMMONIUM HYDROGEN CITRATE",
    "MALIC ACID",
    "NACL AND 0.1M SODIUM ACETATE",
    "ACETATE BUFFER 0.2 M",
    "MES-BIS-TRIS",
    "JCSG+ C6: 40% PEG 300 + 100MM SODIUM PHOSPHATE DIBASIC   SODIUM CITRATE",
    "ZINC ACETATE DIHYDRATE",
    "2-METHYL 2",
    "TRI-AMMONIUM CITRATE 20% W V PEG 3350",
    "PROTEIN AT 2-3 MG ML IN 20 MM TRIS",
    "SODIUM FORMATE (",
    "RESERVOIR SOLUTION : 25% PEG 3350",
    "W V PEG3350 AND 200 MM AMMONIUM CHLORIDE",
    "MANGANESE(II) CHLORIDE TETRAHYDRATE",
    "EQUAL VOLUMES (1UL) OF THE ENZYME-INHIBITOR MIX AND RESERVOIR SOLUTION (0.2 M MNSO4",
    "LITHIUM SULFATE 0.01 M NICKEL CHLORIDE 0.1 M TRIS-HCL",
    "LITHIUM SULFATE 0.02 M COPPER ACETATE 0.1 M TRIS-HCL",
    "MMEPEG 2000",
    "PROTEIN WAS MIXED WITH AN EQUAL VOLUME OF RESERVOIR SOLUTION CONTAINING 1.4 M AMMONIUM SULFATE",
    "PROTEIN IN DEIONISED WATER IS MIXED AT EQUAL VOLUME WITH 51% MPD.",
    "ETHANOL AND 0.1 M TRIS HCL (",
    "SODIUM ACETATE 21% PEG 3350",
    "MES BUFFER (",
    "DISODIUM DL MALATE 200 MM SODIUM THIOSULFATE",
    "1MM TCEP",
    "200NL SEEDED DROPS",
    "A.S.",
    "PRECIPITANT: 25 % WT VOL PEG 2000",
    "25%PEG 4000",
    "PHOSPHATE-CITRATE BUFFER",
    "28-30% PEG",
    "SATURATED AMMONIUM SULFATE",
    "SATURATED AMMONIUM SULFATE SOLUTION CONTAINING 2% (W V) AMBWB BY MICRO-SEEDING THE CRASHED SWMB CRYSTAL",
    "SPONTANEOUS CRYSTALS WERE RECOVERED FROM CONCENTRATED STOCKS OF GTB D302A (68 MG ML) STORED IN 50 MM MOPS",
    "GTB R188K CRYSTALS WERE OBTAINED BY HANGING DROP VAPOR DIFFUSION AT 4 DEGREES C",
    "CAPILLARY COUNTERDIFFUSION METHOD: C23: 0.82 M K-PHOSPHATE",
    "PACT CONDITION C6: 0.1M PCTP BUFFER",
    "ZNSO4 0.1 M MES",
    "WELL SOLUTION: 0.2 M CALCIUM CHLORIDE",
    "PHOSPHOCHOLINE",
    "12-15% PEG 4000 OR PEG 3000",
    "SEEDED 3.4M EQUIMOLAR NA K PHOSPHATE BUFFER",
    "SODIUM ACETATE (PH=4.5)",
    "400 NL 6 MG ML PROTEIN IN 25 MM TRIS",
    "LI2SO4; 0.1M MES",
    "24-34% PEG 4000 200MM TRIS",
    "NA-TARTRATE",
    "POLYETHYLENE GLYCOL (PEG) 4000",
    "RNA; 40 MM SODIUM CACODYLATE",
    "TACSIMATE (6.0); 0.1 M BISTRIS (6.5); 20 % PEG 3",
    "AMMONIUM SULFATE 0.2 M NACL (2X PROTEIN SOLUTION : 1X CRYSTALLISATION CONDITION)",
    "N9 CRYSTALS WERE GROWN BY HANGING-DROP VAPOUR DIFFUSION AGAINST A RESERVOIR OF 1.9M POTASSIUM PHOSPHATE",
    "N9 CRYSTALS WERE GROWN BY-HANGING DROP VAPOUR DIFFUSION AGAINST A RESERVOIR OF 1.9M POTASSIUM PHOSPHATE",
    "TRISCL",
    "19 MG ML GALECTIN-3C",
    "SPG BUFFER AT",
    "100-200 MM CALCIUM ACETATE",
    "RESERVOIR COMPOSITION: 0.3 M SODIUM PHOSPHATE DIBASIC DIHYDRATE",
    "MGSO4",
    "SAMPLE PREINCUBATED WITH 2 MM COPPER(II) ACETATE. RESERVOIR CONSISTING OF 20 MM MGCL2",
    "17-19% PEG3350",
    "PEG2K MME",
    "0.1 TRIS-HCL 2M AMMONIUM SULPHATE",
    "CRYSTALLIZATION BUFFER: 0.1M SODIUM CITRATE (",
    "PEG1000",
    "PEG-1500",
    "1.1-1.3 M AMMONIUM SULFATE",
    "POTASSIUM IODIDE",
    "8-12% PEG3350",
    "PROTEIN: 6.9 MG ML",
    "RBH2PO4",
    "RESERVOIR CONTAINED 15% POLYETHYLENE GLYCOL 8",
    "MPD PEG1000 PEG3350 (MD)",
    "PENTAERYTHRITOL PROPOXYLATE PO OH 5 4",
    "SODIUM CITRATE 50 MM TRIS-HCL",
    "SODIUM CITRATE 50MM TRIS-HCL",
    "OF 20% PEG 6000",
    "WELL SOLUTION CONTAINING 100 MM SODIUM CITRATE",
    "HEPES-NA",
    "PEG MME 5000",
    "DROP: 100 MM TRIS-HCL BUFFER",
    "LACTOSE",
    "18-22% PEG 3350",
    "18-22 % PEG 3350",
    "PEG2000",
    "PHOSPHATE BUFFER AT",
    "HANGING DROPS FORMED FROM MIXING A 1:1 VOLUME RATIO OF THE PROTEIN WITH AN EQUILIBRATION BUFFER CONSISTING OF 16-22% POLYETHYLENE GLYCOL (PEG) MOLECULAR WEIGHT 3350 DA",
    "40-42% PEG 6000",
    "0.1-0.3 M NACL; 0.1 M BIS-TRIS",
    "AMMONIUM SULFATE AND 0.1 M CITRIC ACID",
    "MORPHEUS H2",
    "PURIFIED SATTR IN 100 MM NACL AND 20 MM TRIS-HCL",
    "THE PURIFIED HUMAN TTR WAS DIALYZED AGAINST 10 MM NA-PHOSPHATE BUFFER WITH 100 MM KCL (",
    "20%-25%(W V) PEG 2000 MONOMETHYL ETHER",
    "PEG4000; 0.2M LITHIUM SULFATE; 0.1M TRIS-HCL",
    "20-30% PEG4000; 0.2M LITHIUM SULFATE; 0.1M TRIS-HCL",
    "20-30%PEG4000; 0.2M LITHIUM SULFATE; 0.1M TRIS-HCL",
    "DMSO",
    "1.43-1.48 M (NH4)2SO4 300-400 MM NASCN 1.5% ISOPROPANOL 14.0 MG ML PROTEIN IN 20 MM TRIS",
    "1.43-1.48 M (NH4)2SO4 300-400 MM NASCN 1.5% ISOPROPANOL 2:1 RATIO OF RMA TDE (14 MG ML IN 20MM TRIS HCL",
    "NH4AC",
    "W V PEG 20000 20% PEG 500 MME 0.02 M 1",
    "W V PEG 20000 20% PEG 500 MME 0.03 M DIETHYLENEGLYCOL 0.03 M TRIETHYLENEGLYCOL 0.03 M TETRAETHYLENEGLYCOL 0.03 M PENTAETHYLENEGLYCOL 0.1 M BICINE TRIZMA",
    "MIB (SODIUM MALONATE:IMIDAZOLE:BORIC ACID IN MOLAR RATIOS OF 2:3:3) BUFFER (",
    "ETHYLENE GLICOL",
    "19-21 % PEG 3350 AND 50 MM MG ACETATE",
    "AMMONIUM CHLORIDE 20% W V PEG 3350",
    "PURIFIED CSEP0064 BEC1054 WAS DIALYSED INTO CRYSTALLISATION BUFFER (10 MM TRIS",
    "OF #F1 INHIBITOR (IN DMSO) FINAL CONCENTRATION. RATIO 1:1 (PROTEIN:PRECIPITANT). 20MG ML OF BRD4(BD1) PROTEIN. 0.25M AMSO4; 0.1M NACL; 0",
    "OF #17 INHIBITOR (IN DMSO) FINAL CONCENTRATION. RATIO 1:1 (PROTEIN:PRECIPITANT. 12MG ML OF BRD4(BD1) PROTEIN. PRECIPITANT AGENT: 0.3M NANO3; 0.1M NACL; 22% (W V) PEG3350; 10% (W V) ETHYLENE GLYCOL. CRYOPROTECTANT: 10 % (W V) GLYCEROL.",
    "0.1 M",
    "NAACT",
    "- 34% PEG 4000",
    "200 NL 7 MG ML PROTEIN + 200 NL RESERVOIR (2.8 M AMMONIUM SULFATE",
    "ETHYLENE GLYCOLS (0.3M DIETHYLENE GLYCOL; 0.3M TRIETHYLENE-GLYCOL; 0.3M TETRAETHYLENE GLYCOL; 0.3M PENTAETHYLENE GLYCOL); 0.1M BUFFER SYSTEM 3 (1M TRIS (BASE); BICINE)",
    "AMINO ACIDS (0.2M L-NA-GLUTAMATE; 0.2M ALANINE (RACEMIC); 0.2M GLYCINE; 0.2M LYSINE HCL (RACEMIC); 0.2M SERINE (RACEMIC)); 0.1M BUFFER SYSTEM 2 (1M SODIUM HEPES",
    "ALCOHOLS (0.2M 1",
    "CRYSTALS GREW IN 16-20 MG ML PROTEIN SOLUTION AND IN 30 % W V PEG 8",
    "PEG1000 -- 0.1M MIB",
    "PEG3350 -- 10% ETHYLENE GLYCOL -- 0.1M BIS-TRIS-PROPANE",
    "DROP: 10 MG ML PKA (0.240 MM) 30 MM MBT (MES BIS-TRIS PUFFER",
    "PROTEIN BUFFER: 20 MM TRIS-HCL",
    "PEG 6000 20%; HEPES 0.1 M",
    "PEG 6000 20% HEPES 0.1 M",
    "DIVALENT",
    "MIDAS 1-30: 40% 5 4 PO OH 100 MM MES",
    "MORPHEUS 1-9: 60MM DIVALENT",
    "18-24%PEG4000",
    "BIS-TRIS 1.8 M AMMONIUM SULPHATE",
    "MAGNESIUM FROMATE DIHYDRATE",
    "ELANA.00074.A.B1.PW38309 + MCSG1 D4 (294273D4) (200 MM SODIUM THIOCYANATE",
    "BUPHA.00010.X.B1.PS37816 + 4 MM NADP + MORPHEUS G2 (269916G2) (10% W V PEG8000",
    "22-25% PEG3350",
    "PROTEIN TO PRECIPITANT SOLUTION: 1.5 MICROL:1.5 MICROL PROTEIN: 12 MG ML 20 MM TRIS",
    "SODIUM FLUORIDE; 30MM SODIUM BROMIDE; 30MM SODIUM IODIDE; 100MM TRIS(BASE) BICINE",
    "0.05 TO 0.3 M LI2SO4",
    "AMMONIUM CHLORIDE 20% PEG 3",
    "PEG 3350 200 MM SODIUM MALONATE",
    "WT VOL PEG-8000",
    "SODIUM CITRATE AT",
    "SODIUM ACETATE 4.6",
    "PROTEIN WAS AT 10 MG ML AND WAS SET UP IN 250 PLUS 250 NL DROPS WITH A RESERVOIR OF 50 MM TRIS",
    "200 NL 7 MG ML PROTEIN + 200 NL RESERVOIR SOLUTION (2.9 M AMMONIUM SULFATE",
    "2.1-2.3 M AMMONIUM SULFATE",
    "10-25% PEG3350 WITH 0.2 M MGCL2; II) 10-25% PEG3350 WITH 0.2 M AMMONIUM ACETATE",
    "MAGNESIUM FORMATE DEHYDRATE",
    "SODIUM NITRITE",
    "PEG3350 10% ETHYLENE GLYCOL 0.2M SODIUM IODIDE",
    "PEG3350 10% ETHYLENE GLYCOL 0.1M BIS-TRIS-PROPANE",
    "PEG1000 0.1M PCB",
    "SODIUM PHOSPHATE BUFFER",
    "1-ML MIXTURE CONTAINING 120 MM POTASSIUM PHOSPHATE",
    "BUFFER FOR CRYSTALLIZATION: 0.1 M SODIUM ACETATE",
    "15-25% PEG3350 AND 0.1 M NA HEPES",
    "PROTEIN: 1 MICRO-L MMP12 AT 290 MICRO-M WITH 10 MILLI-M ACETOHYDROXAMATE + 0.1 MICRO-L BE6 FROM 10 MILII-M IN 100% DMSO PRECIPITANT: 17% PEG 20K",
    "PROTEIN SOLUTION: HMMP12 AT 314 MICRO-M + 10 MILLI-M ACETOHYDROXAMATE + 1 MILLI-M BE4",
    "DROP: 1 MICRO-L (HMMP-12 AT 855 MICRO-M + 1 MILLI-M HYDROXAMIC ACID + 1 MILLI-M LP165) AND 1 MICRO-L RESERVOIR SOLUTION. PRECIPITANT: 17% PEG 20K",
    "PROTEIN: HUMAN MMP9 E402Q 300 MICRO-M PRECIPITANT: 31.5% MPEG 5K; .14 M IMIDAZOLE PIPERIDINE;",
    "BICINE 10% PEG 6000 0.25M NACL",
    "PROTEIN SOLUTION: 6 MG ML PROTEIN IN 25 MM SODIUM PHOSPHATE",
    "42%MPD",
    "ETHANOL",
    "TOPS SCREEN",
    "GALECTIN-3C",
    "PROTEIN CONCENTRATION 40 MG ML WELL 25% W V PEG MME 3350",
    "RESERVOIR: 500 UL OF 25 MM HEPES",
    "PROTEIN 10 MG ML WAS MIXED WITH AN EQUAL VOLUME OF A RESERVOIR SOLUTION CONTAINING 200 MM NACL",
    "MOLECULAR DIMENSIONS MORPHEUS SCREEN",
    "AMMONIUM CHLORIDE WITH 20% PEG 8000 CRYSTAL GROWTH TIME WAS IMPROVED USING MICRO-SEEDING CRYSTALS WERE CRYOPROTECTED USING THE CRYSTALLISATION CONDITION SUPPLEMENTED WITH 25% (W W) GLYCEROL",
    "AMMONIUM CHLORIDE WITH 20% PEG 8000 CRYSTAL GROWTH TIME WAS IMPROVED USING MICRO-SEEDING CRYSTALS WERE CRYOPROTECTED USING THE CRYSTALLISATION CONDITION SUPPLEMENTED WITH 25% (W W) GLYCEROL CRYSTAL WAS CO-CRYSTALLISED WITH 10MM 2",
    "HEPES-NA (",
    "LYSOZYME IN 20 MM TRIS",
    "THERMOLYSIN IN 0.05 M NAOH 1:1 WITH 40 MM KH2PO4",
    "(W V) PEG1000",
    "PACT SCREEN",
    "PHOSPHATE CITRATE 4.2",
    "BIS TRIS PROPANE 8.5",
    "PROTEIN DIALYZED AGAINST 50 MM TRIS(HYDROXYMETHYL)AMINOMETHANE-HCL",
    "PEG 4K 0.01 M SODIUM CITRATE",
    "AMMONIUM PHOSPHATE MONOBASIC",
    "100 MM HEPES",
    "AADTWE CRYSTALS WERE GROWN FROM A SOLUTION CONTAINING 100 MG ML PEPTIDE. THE RESERVOIR CONTAINED 0.2 M AMMONIUM PHOSPHATE MONOBASIC",
    "NICKEL CHLORIDE HEXAHYDRATE",
    "NH4SO4 AND 0.1M BTP 7.0",
    "PEG 5K MME",
    "PACT PREMIER SOLUTION A04: 0.1 M SPG BUFFER",
    ".1M NA ACETATE",
    "PEG 3350 AND 0.1 M CITRATE",
    "K(CITRATE) 0.1 M CACODYLATE",
    "PEG1000 0.1M MMT",
    "51-63% MPD AND 0.1M SPG BUFFER",
    "PEG MME 550",
    "17-23% PEG20K",
    "12.5 MG ML BRD4",
    "CONTAINING 22% PEG 4000",
    "BRABA.00029.A.A1.PB00087 WITH EMERALD BIOSTRUCTURES PRIMARY PRECIPITANT #18 (2 M LITHIUM SULFATE",
    "PEG 6000 100MM TRIS",
    "800 NL DROPS WITH PROTEIN-TO-MOTHER LIQUOR AT A RATIO OF 1:1",
    "RESERVOIR SOLUTION CONTAINED 4M SODIUM FORMATE",
    "SATURATED AMMONIUM SULFATE BUFFERED WITH NA PHOSPHATE AT",
    "NA-TARTRATE (0.52M)",
    "10-13 % PEG 8000 15-20 % ETHYLENE GLYCOL 0.03 M MGCL2 0.1 MM ZNCL2 5 MM NA2S2O4 0.1 M HEPES NAOH",
    "PEG4000; 0.1M MES",
    "PROTEIN IN A SOLUTION CONTAINING 2.0 M AMMONIUM SULFATE AND 0.1 M SODIUM CITRATE (",
    "MIB (MIXTURES OF SODIUM MALONATE",
    "NH4(SO4)",
    "18%PEG4000",
    "2% (V V) PEG 400 0.1 M HEPES PH. 7.5",
    "NA-FORMATE",
    "CITRATE BUFFER AT",
    "SODIUM THIOCYANATE 200 MM",
    "MEPEG 5000",
    "SARO PROTEIN AT 277 MM WAS INCUBATED WITH 10 MM REDUCED GLUTATHIONE FOR 50 MINUTES PRIOR TO SETTING UP CRYSTALLIZATION EXPERIMENTS. AN EQUAL VOLUME OF PROTEIN SOLUTION AND RESERVOIR WERE DEPOSITED BY A TTP LABTECH MOSQUITO IN A SD2 CRYSTALLIZATION PLATE AND ALLOWED TO EQUILIBRATE. THE CRYSTALS WERE SELF-CRYOPROTECTED BY THE RESERVOIR OF 4 M AMMONIUM ACETATE.",
    "SARO PROTEIN AT 277 MM WAS INCUBATED WITH 10 MM REDUCED GLUTATHIONE FOR 50 MINUTES PRIOR TO SETTING UP CRYSTALLIZATION EXPERIMENTS. THE DROPLET YIELDING THE CRYSTAL WITH THE HIGHEST OBSERVED DIFFRACTING POWER WAS COMPOSED OF 130 NL PROTEIN AND 85 NL RESERVOIR SOLUTION. THE RESERVOIR SOLUTION WAS 1.35 M AMMONIUM SULFATE",
    "HEPES BUFFER (",
    "POLYETHYLENE GLYCOL 6000 (PEG 6000)",
    "20-30%PEG3350",
    "20-30% PEG3350",
    "AMMONIUM SULFATE; 0.1 M BUFFER ACID CITRIC",
    "PEG3000",
    "SODIUM ACETATE TRIHYDRATE 20% (+ -) 2-METHYL-2",
    "HALOGENS (NAF",
    "FORMATE",
    "NA3CIT",
    "18-20% PEG-5000",
    "FREE-INTERFACE DIFFUSION OF A 10 UL OF 30 MG ML-1 PROTEIN SOLUTION",
    "W V 2-PROPANOL",
    "METHANOL",
    "CRYSTALLIZATION CONDITION 20% PEG 8K",
    "30%PEG4K",
    "SODIUM CITRATE 100 MM TRISHCL",
    "MAGNESIUM ACETATE PEG 3350",
    "SODIUM CITRATE AND 50 MM TRIS",
    "BUFORMIN",
    "TRIS -HCL PH- 8.0",
    "NA CITRATE 20% (W V) PEG 3",
    "MAGNESIUM FORMATE 20 % PEG 3350",
    "SPG (",
    "CALCIUM CHLORIDE DEHYDRATE",
    "NASCN",
    "PROTEIN: 10.4 MG ML",
    "CRYSTALLIZATION RESERVOIR SOLUTION: 25 % PEG3350",
    "WELL: 3.0M (NH4)2SO4 DROP: 50MM KMOPS",
    "RESERVIOR: 25% PEG 3350",
    "8-12% PEG 5000",
    "20-30 % (W V) PEG 8000 AND 50 MM TRIS-HCL BUFFER (",
    "SPERMINE TETRAHYDROCHLORIDE",
    "0.2 AMMONIUM ACETATE",
    "PROTEIN: 9.7 MG ML",
    "1 PART PROTEIN SOLUTION (20.0 MG ML IN 20 MM TRIS-HCL",
    "TRIS-HCI",
    "1:1 PROTEIN (5 MG ML IN 2.5 MM SODIUM FORMATE",
    "TRIS-HCL 0.1M AMMONIUM SULFATE 3.2M",
    "CRYSTALLIZATION: 2 UL PROTEIN SOLUTION IN 50 MM TRIS",
    "PEG8K 50 MM AMSO4 0.1M TRIS-HCL",
    "NABORATE",
    "CDK2 10% V V PEG3350",
    "SODIUM DIHYDROGEN PHOSPHATE",
    "PEG6K",
    "0.6 UL 0.4 MM D(CGCGCG)2 SOLUTION MIXED WITH 1.2UL OF THE PRECIPITANT SOLUTION CONSISTING OF 10 MM CACL2",
    "PEG1000 -- 0.1M SPG",
    "NA-PHOSPHATE",
    "13-15% PEG8000",
    "CONCANAVALIN A IN 0.025 M HEPES",
    "LYSOZYME WAS DISSOLVED IN 0.02 M SODIUM ACETATE",
    "POTASSIUM PHOSPHATE MONOBASIC AND 16 % W V PEG8000 AND 20 % V V GLYCEROL AT A PROTEIN CONCENTRATION OF 21.9 MG ML",
    "22-24% PEG 3350",
    "DI NAH PHOSPHATE AND 20% PEG3350",
    "SPG (SUCCINIC ACID",
    "MPD 57%",
    "TRIS-CL",
    "V V PEG 400",
    "7.8 MONOACYLGLYCEROL (7.8 MAG)",
    "PEG 10000",
    "PEG 8000 0.1 M HEPES",
    "TRI-AMMONIUM CITRATE",
    "PEG-1000 100MM SODIUM ACETATE",
    "SODIUM POTASSIUM PHOSPHATE 20% (W V) PEG 3350",
    "HEPES BUFFER",
    "HEPES 7.0",
    "3-(N- MORPHOLINO)PROPANESULFONIC ACID",
    "PEG20000",
    "NACL + 0.1 M ACETATE",
    "CACL2 AND 37.5% V V MPD",
    "RESERVOIR CONTAINED 20% PEG 3350",
    "RESERVOIR CONTAINED 20% PEG 4000",
    "SODIUM MALONATE-MALONIC ACID",
    "OPTIMISED FROM MORPHEUS SCREEN: MES IMIDAZOLE",
    "NACL 0.1 M CITRIC ACID",
    "(10 MM MONOBASIC POTASSIUM PHOSPHATE",
    "BISTRISPROPANE",
    "NAH2PO4 K2HPO4",
    "PEG4000 .1 M NA CITRATE (",
    "SODIUM IODIDE AND 20% (W V) POLYETHYLENE GLYCOL 3350",
    "16-19% PEG 8K",
    "AMMONIUM IODIDE",
    "100 MM MES",
    "AMMONIUM ACETATE 0.1M SODIUM ACETATE",
    "PROTEIN (15 MG ML); RESERVOIR (0.17 M SODIUM ACETATE",
    "CONCENTRATED CA II AT ~10 MG ML WAS SET UP IN SD-2 PLATES (MOLECULAR DIMENSIONS) WITH THE FOLLOWING RATIO OF PROTEIN PLUS RESERVOIR PLUS SEEDS: 250 NL + 225 NL + 25 NL. THE PLATE WAS INCUBATED AT 8 C AND THE RESERVOIR CONDITION CONSISTED OF 2.9 M AMMONIUM SULFATE WITH 0.1 M TRIS BUFFER AT",
    "CONCENTRATED CA II AT ABOUT 10 MG ML WAS SET UP IN SD-2 PLATES WITH THE FOLLOWING RATIO OF PROTEIN PLUS RESERVOIR PLUS SEEDS: 250NL PLUS 225 NL PLUS 25 NL. THE PLATE WAS INCUBATED AT 8C AND THE RESERVOIR CONDITION CONSISTED OF 2.9 M AMMONIUM SULFATE WITH 0.1 M TRIS BUFFER AT",
    "POLYETHYLENE GLYCOL 1000",
    "MAGNESIUM ACETATE 0.1M SODIUM CACODYLATE",
    "POTASSIUM CHLORIDE 0.1M HEPES",
    "MAGNESIUM CHLORIDE 0.1M SODIUM CITRATE",
    "MAGNESIUM ACETATE 0.1M MOPS",
    "PEG20000 0.1 M SODIUM CITRATE AT",
    "1UL OF PROTEIN AT 20MG ML MIXED WITH 1UL OF MOTHER LIQUOR",
    "PEG3350 0.2M DISODIUM MALONATE 0.01 M HEPES",
    "BJP-1 (10 MG ML-1 IN 0.1 M TRIS-HCL",
    "LITHIUM SUPLHATE",
    "MG FORMATE DIHYDRATE",
    "CRYSTALLIZATION BUFFER 24% PEG 3350",
    "AMSO4 0.1M CITRIC ACID",
    "IMIDAZOLE MALATE (",
    "PEG400 AND 100 MM MGCL2",
    "BIS-TRIS 5.5",
    "CA-ACETATE",
    "CRYSTAL REAGENT (1.5 UL): 10% W V PEG 20000",
    "CAOAC",
    "TRAY 291037 MORPHEUS A3: 10% W V PEG 4000",
    "TRI-SODIUM CITRATE (",
    "DIOXANE",
    "PEG 2000",
    "THE RESERVOIR CONDITION CONSISTED OF 2.9 M AMMONIUM SULFATE WITH 0.1 M TRIS BUFFER AT",
    "PROTEIN WAS CONCENTRATED TO 13MG ML",
    "CONCENTRATED CA II AT 10 MG ML WAS SET UP WITH MICROSEEDING OVER 2.9 M AMMONIUM SULFATE WITH 0.1 M TRIS BUFFER AT",
    "TACSIMATE 6.0",
    "PRECIPITANT: 200 MM MGCL2",
    "PERCIPIENT: 200 MM CACL2",
    "1.0 TO 1.4 M SODIUM CITRATE",
    "1.0 - 1.4M SODIUM CITRATE",
    "22-24% PEG 8000",
    "DROPLETS (2 UL) CONTAINING OLIGONUCLEOTIDE (0.23 MM)",
    "DHP B IN 20 MM NA CACODYLATE (",
    "2.0 UL OF PROTEIN SOLUTION (10.5 MG ML IN 50 MM TRIS PH=7.8) WERE MIXED WITH 2.0 UL OF THE WELL SOLUTION (2.7 M (NH4)2SO4",
    "50 MM TRIS HCL",
    "1 UL 59 MG ML EFE (1.2 MM MANGANESE CHLORIDE",
    "0.2 UL 64 MG ML EFE (+4 MM MANGANESE CHLORIDE",
    "0.5 UL 64 MG ML EFE (+1 MM MANGANESE CHLORIDE",
    "0.2 UL 64 MG ML EFE (+1 MM MANGANESE CHLORIDE",
    "0.5 UL 72 MG ML SELENOMETHIONINE CONTAINING EFE (9 MM MANGANESE CHLORIDE",
    "0.5 UL 5-RA5-DA-RA5 AND RRM23 (98-269) IN 10 MM HEPES",
    "PROTEIN: 8.0 MG ML",
    "RESERVOIR: 0.1 M KSCN",
    "TRIS-HCL CONTAINING 200 MM SODIUM ACETATE",
    "MGCL2 AND 100 MM BICINE (",
    "NH4 FORMATE",
    "23-28% PEG 3350 (V V)",
    "LITHIUM SULFATE MONOHYDRATE. 0.1 M SODIUM ACETATE TRIHYDRATE",
    "HIGHPEG",
    "PEG 4000 26 % AND TRIS HCL 0",
    "PROTEIN IN 20 MM CACODYLATE",
    "TNFA (VCID10616",
    "SODIUM CHLORIDE 0.3M HEPES 7.2 0.1M PEG 3350 25%",
    "10-13 % (W V) OF POLYETHYLENE GLYCOL 8000 15-20 % (V V) OF ETHYLENE GLYCOL 0.03 M MGCL2 0.1 MM ZNCL2 5 MM NA2S2O4 0.1 M OF HEPES NAOH",
    "3.0-3.2 M (NH4)2SO4",
    "DI-AMMONIUM HYDROGEN CITRATE SALT AND 20% (W V) PEG 3350",
    "MAGNESIUM FORMATE SALT",
    "NA-HEPES",
    "30-35% PEG 4000",
    "SODIUM IODIDE",
    "14 OR 15% PEG3350",
    "NAH2PO4 1.6M K2HPO4",
    "CO-CRYSTALS OF CARMM RED DOMAIN WITH NADP WERE OBTAINED IN 0.2 M SODIUM SULPHATE",
    "SODIUM ACETATEBUFFER (",
    "TACSIMATE (",
    "CRITIC ACID",
    "MGL 20MG ML",
    "W V PEG 3000 100 MM SODIUM CITRATE",
    "PEG 3350 100 MM HEPES",
    "SODIUM MALONATE 20% POLYETHYLENE GLYCOL (PEG) 3350.",
    "WT-TTR AT 4 MG ML AND FIVE-FOLD MOLAR EXCESS COMPOUND 201 CRYSTALLIZED FROM SOLUTION CONTAINING 1.395 M SODIUM CITRATE",
    "PROTEIN BUFFER :",
    "CADMIUM SULFATE HYDRATE",
    "AMMONIUM SULFATE; 0.1 M HEPES",
    "CSCL",
    "HEPES NA",
    "TLN",
    "DROPS CONSISTING OF EQUAL VOLUMES (1 MICROLITER) OF PROTEIN COMPLEX (AT 6.4 MG ML) AND PRECIPITANT SOLUTION (0.1M PCTP",
    "PCTP",
    "NATIVE CRYSTALS OF GTA GTB LACKING ANY HEAVY METALS WERE GROWN AT 4 DEGREES CELSIUS FROM MUCH HIGHER CONCENTRATIONS OF PROTEIN (30-40 MG ML FOR GTB AND 16-20 MG ML FOR GTA) ALONG WITH 1% PEG 4000",
    "OLIGONUCLEOTIDE",
    "PEG2000 MME",
    "PEG 4000 150 MM AMMONIUM SULFATE",
    "PEG400 0.2 M LITHIUM SULPHATE 0.1 M SODIUM ACETATE 2.5 MM ADENOSINE",
    "CACL2 0.1 M HEPES SODIUM",
    "IMIDAZOLE MALATE",
    "BAR PROTEIN WAS INCUBATED WITH 1 MM ACETYL-COA FOR >2 HOUR PRIOR TO SETTING CRYSTAL TRAYS. CRYSTALS OF BAR WERE OBTAINED AFTER 3 DAYS AT 20C IN HANGING DROPS CONTAINING 1 UL OF PROTEIN SOLUTION (7.5 MG ML) AND 1 UL OF RESERVOIR SOLUTION (0.18 M CALCIUM ACETATE",
    "1.8-2.0 M AMMONIUM SULFATE",
    "PROTEIN STOCK IN MIXED 1:1 WITH 1.2 M NAH2PO4 K2HPO4 (1:9 V V) AT 293 K.",
    "MES IMIDAZOLE BUFFER",
    "MES IMIDAZOLE",
    "CRYSTALS WERE OBTAINED BY MIXING A SOLUTION OF 22 MG ML PROTEIN AND 1.5 MM INHIBITOR WITH 0.1 M SODIUM ACETATE (",
    "PEG 4000 15 % GLYCEROL 0.1 M CITRIC ACID",
    "PEG 3350 0.2 M SODIUM NITRATE",
    "1UL PROTEIN SOLUTION AT 20 MG ML (20 MM TRIS",
    "1UL PROTEIN SOLUTION AT 10 MG ML (20 MM TRIS",
    "(W V) PEG3350",
    "PHOSPHATE NH4 DIBASIC 0.07M PHOSPHATE K DIBASIC 0.03M PHOSPHATE NA MONOBASIC",
    "PURIFIED ENZYME WAS INCUBATED WITH A THREEFOLD MOLAR EXCESS OF CUSO4 FOR 30 MIN AT ROOM TEMPERATURE. TO REMOVE EXCESS COPPER",
    "MCSG1 H10 (289135H10): 25% PEG3350",
    "MCSG1 G4 (291317G4): 100MM POTASSIUM TARTRATE",
    "PEG 2000 MME 50MM TRIS 8.5",
    "OD280=17.7 MG ML IN 20 MM HEPES",
    "HEPES 2 M AMMONIUM SULFATE 2 % PEG-400",
    "BUPHA.00104.A.B1.PS37967 AT 22.6MG ML",
    "PEG3350+0.2 M NH4CL",
    "CRYSTALS WERE GROWN BY THE VAPOUR DIFFUSION HANGING DROP METHOD USING A FERRIC PROTEIN SOLUTION AT 13 MG ML EQUILIBRATED AGAINST A RESERVOIR CONSISTING OF 17-24% PEG 3000 AND 50-100 MM SODIUM CITRATE",
    "PROTEIN SOLUTION (12MG ML",
    "SODIUM CHLORIDE (80 MM) POTASSIUM CHLORIDE (12 MM) MAGNESIUM CHLORIDE (20 MM) SPERMINE TETRAHYDROCHLORIDE (12 MM) SODIUM CACODYLATE (40 MM",
    "10 MG PROTEIN ML DIALYZED AGAINST 50 MM AMMONIUM N-[TRIS(HYDROXYMETHYL)METHYL]-2-AMINOETHANESULFONATE BUFFER",
    "PEG 4K 10% ISOPROPANOL 0.1M HEPES",
    "PROTEIN: 7 MG ML IN 50MM SODIUM ACETATE",
    "DTT",
    "ENZYME DIALYZED AGAINST 50 MM AMMONIUM N-[TRIS(HYDROXYLMETHYL)METHYL]2-AMINOETHANE SULFONATE (",
    "PEG3350 AND 200 MM CH3CO2K",
    "PEG3350 AND 200 MM POTASSIUM ACETATE",
    "22-30% (W V) PEG 1450",
    "20-25% PEG-5000",
    "24-28% PEG-5000",
    "50 MM CHES",
    "POLYETHYLENE GLYCOL",
    "17-20% PEG 3350",
    "PROTEIN: 14.6 MG ML",
    "KPO4",
    "ZNCL2; 0.1M MES",
    "W V PEG20000",
    "PEG 3350 AND 0.2 M LITHIUM ACETATE",
    "W V PEG8K",
    "HEN EGG WHITE LYSOZYME",
    "SODIUM ACETATE; 34% PEG4000; 225MM AMMONIUM ACETATE",
    "PROTEIN WAS CRYSTALLIZED FROM 0.1 M MES IMIDAZOLE",
    "GAL3C WITH A RESERVOIR OF 100 MM TRIS-HCL",
    "PEG3500",
    "POTASSIUM SULFATE",
    "SODIUM CITRATE DEHYDRATE",
    "0.2MOL L CACL2",
    "PEG 1500 (W V) AND 0.1 MM TRIS-HCL",
    "PEG 3350 AND 0.2M SODIUM MALONATE",
    "PROTEIN AT 8 MG ML IN 0.8-1.2 M SODIUM CITRATE AS PRECIPITANT WITH 10MM SODIUM BORATE AT",
    "PEG600 -- 0.1M MES",
    "SALT: 0.2 M AMMONIUM SULFATE PRECIPITANT: 11.4 %W V PEG 8000 BUFFER: 0.1 M HEPES (",
    "SALT: 0.2 M AMMONIUM SULFATE PRECIPITANT: 14.1 %W V PEG 8000 BUFFER: 0.1 M HEPES (",
    "POLYETHYLENE GLYCOL 3",
    "PEG3350 -- 0.1M HEPES",
    "MES-BIS-TRIS-BUFFER",
    "RESERVOIR COMPOSITION: 28 % (W V) PEG6000",
    "HEPES PH-7.3",
    "PHOSPHATE CITRATE",
    "CADMIUM CHLORIDE",
    "TRIS HYDROCHLORIDE",
    "SODIUM ACETATE TRIHYDRATE 0.1 M BIS-TRIS PROPANE 7.5 20 % W V PEG 3350",
    "PEG1000 0.1M MIB",
    "PEG 1500 5% DMSO 0.1 M MIB",
    "CO-CRYSTALLIZATION WITH THE COMPOUND WAS ACHIEVED BY EQULIBRATING A 6.25 MG ML PROTEIN SOLUTION IN 20 MM HEPES BUFFER (",
    "PEG 1500 25%",
    "AMMONIUM SULFATE AND 5% ISOPROPANOL",
    "PEG 6",
    "AMMONIUM SULFATE 0.1 M SODIUM CITRATE TRIBASIC DEHYDRATE 1.0 M LITHIUM SULFATE MONOHYDRATE 1.0 M GUANIDINE HYDROCHLORIDE",
    "TRIS 8.5 PH",
    "HALOGENS",
    "NAK TARTRATE 1 M",
    "BICINE 9.0 PH",
    "PROTEIN: 6.3 MG ML",
    "0.3 UL OF 10 MG ML PROTEIN INCUBATED WITH 5MM COA WAS MIXED WITH 0.2 UL OF THE WELL CONDITION (MCSG SUITE I CONDITION 11 - 100 MM TRIS-HCL",
    "NA2HPO4 0.4M K2HPO4 0.1M SODIUM CITRATE PHOSPHATE",
    "CHES 0.1 M",
    "NAH2PO4 (",
    "AMSO4 + 0.1M TRIS",
    "W V PEG6000",
    "DL-GLUTAMIC ACID MONOHYDRATE; 0.1M DL-ALANINE; 0.1M GLYCINE; 0.1M DL-LYSINE MONOHYDROCHLORIDE; 0.1M DL-SERINE; 0.1M IMIDAZOLE; MES MONOHYDRATE (ACID)",
    "RESERVOIR SOLUTION: 1:10 DILUTION OF 0.2% (W V) CAFFEINE",
    "PEG 3350 CONTAINING 0.2 M POTASSIUM THIOCYANATE",
    "20 MG ML GALECTIN-3C",
    "200 NL OF A SOLUTION CONTAINING 59 MG ML PROTEIN",
    "1 UL 20 MG ML PROTEIN + 1 UL 24% W V PEG6000",
    "1 MICROLITER OF PROTEIN AT XXXX WAS COMBINED WITH 1 MICROLITER OF RESERVOIR SOLUTION CONSISTING OF 31%W V PEG3350",
    "BIS-TRIS(",
    "BIS-TRIS 5.5 25% W VPEG 3350",
    "INSULIN",
    "MORPHEUS E8 (305593E8): 12.5% (W V) PEG1000",
    "WELL CONDITION: 100 MM TRI-HCL (",
    "5 UL RESERVOIR + 5 UL 25 UM 157C DELTA C-STAR HUMAN H-CHAIN FERRITIN IN 15 MM HEPES",
    "MGGH51 IN 10 MM NAOAC",
    "POLYETHYLENE GLYCOL 1500",
    "W V ETHYLAMMONIUM NITRATE",
    "STMAA.00085.A.B1.PW38702 AT 24.25 MG ML WAS COMBINED 1:1 (0.4 UL PROTEIN PRECIPITANT) WITH 0.2 M AMMONIUM CITRATE DIBASIC",
    "AMSO4 291MM NANO3",
    "SODIUM CITRATE AND 50MM TRIS",
    "LITHIUM CHLORIDE 0.1 M TRIS",
    "HEPES (PH-7.5)",
    "200 NL 37 MG ML PROTEIN",
    "PEG 4000 (32% W V)",
    "1.6 SODIUM CITRATE",
    "TRIS PH=7.8 1.6 M NATRIUM CITRATE",
    "PROTEIN SOLUTION (10 G L LBADH",
    "MAGNESIUM CHLORIDE 0.1 M NA HEPES 7.5 10 % W V PEG 4000",
    "PEG 3350 0.2M NABR",
    "CRYSTALS GROWN BY HANGING DROP VAPOUR DIFFUSION. A 1:1 MIXTURE OF PROTEIN SOLUTION AND AN 8:4 MIXTURE OF K2HPO4 TO KH2PO4 WAS PLACED ABOVE A WELL OF AN 8:6 SOLUTION OF K2HPO4 TO KH2PO4. THEN SERIALLY CRYOPROTECTED IN SITU TO 40% GLYCEROL (V V WITH MOTHER LIQUOR) IN 10% INCREMENTS OVER A PERIOD OF A FEW MINUTES. A 2.5MM SOLUTION OF ISOCARBA-DANA WAS THEN SOAKED INTO THE RESULTANT CRYSTALS FOR 90 MINUTES AT A TEMPERATURE OF 293K.",
    "KNA-TARTRATE",
    "CRYSTALLIZATION BUFFER WAS 0.1M SODIUM BICINE",
    "W V TACSIMATE",
    "SODIUM THIOCYANATE AND 20% POLY ETHYLENE GLYCOL (PEG) 3350",
    "CRYSTALS WERE GROWN BY VAPOR DIFFUSION AT ROOM TEMPERATURE IN 24 WELL CRYSCHEM SITTING DROP PLATES (HAMPTON RESEARCH",
    "CRYSTALS GROWN BY SITTING DROP WITH 0.6 UL RESERVOIRS OF 20% PEG 3350 IN 0.1 M MES BUFFER AT",
    "CRYSTALLIZED BY SITTING DROP IN CRYSCHEM PLATES USING 0.6 ML RESERVOIRS OF 20% PEG 3350 IN 0.10 M MES BUFFER. 8 UL DROPS COMPOSED OF EQUAL AMOUNTS OF ENZYME IN WATER AT 30 MG ML AND THE RESERVOIR SOLUTION",
    "PKA",
    "SODIUM FORMATE; 0.1M AMMONIUM ACETATE; 0.1M SODIUM CITRATE TRIBASIC DIHYDRATE; 0.1M POTASSIUM SODIUM TARTRATE TETRAHYDRATE; 0.1M SODIUM OXAMATE 0.1M SODIUM HEPES; 0.1M MOPS 10% V V ETHYLENE GLYCOL; 8 % W V PEG 8000",
    "PHOSPHATE; 0.1 M BIS-TRIS PROPANE",
    "PEG 3350 AND 100 MM BIS-TRIS",
    "V V 2-PROPANOL",
    "15-23% PEG3350 AND 200 MM AMMONIUM NITRATE",
    "ANAEROBY",
    "POLYETHYLENE GLYCOL 3350 AND 0.2 M NABR",
    "CRYSTALS GROWN BY HANGING DROP VAPOUR DIFFUSION. A 1:1 MIXTURE OF PROTEIN SOLUTION AND AN 8:4 MIXTURE OF K2HPO4 TO KH2PO4 WAS PLACED ABOVE A WELL OF AN 8:6 SOLUTION OF K2HPO4 TO KH2PO4. THEN SERIALLY CRYOPROTECTED IN SITU TO 40% GLYCEROL (V V WITH MOTHER LIQUOR) IN 10% INCREMENTS OVER A PERIOD OF A FEW MINUTES.",
    "MNS04",
    "PEG3350 20%",
    "PENTAERYTHRITOL ETHOXYLATE; 0.2 M POTASSIUM ACETATE; 3% (V V) JEFFAMINE T-403; 0.1 M MES",
    "CALCIUM ACETATE HYDRATE 0.1 M TRIS",
    "PROTEIN IN 20 MM",
    "PURIFIED HAK3 WAS DIALYZED AGAINST 30 MM MOPS BUFFER WITH 50 MM NACL",
    "CITRATE BUFFER (",
    "CITRIC ACID (",
    "CRYSTALS GREW IN 0.1 M SODIUM ACETATE",
    "DL-GLUTAMIC ACID MONOHYDRATE; 0.1M DL-ALANINE; 0.1M GLYCINE; 0.1M DL-LYSINE MONOHYDROCHLORIDE; 0.1M DL-SERINE; 0.1 M TRIS (BASE); BICINE",
    "19-21.5% PEG3350",
    "PEG600",
    "HEPES 30% W V PEG 6000 CRYOPROTECTED BY ADDITION OF 20% V V GLYCEROL",
    "SODIUM-POTASSIUM PHOSPHATE",
    "SODIUM ACETATE 0.2M",
    "NAF AND 16% (W V) PEG3350",
    "24-34% PEG 4000 200MM SODIUM ACETATE 100MM TRIS",
    "24-34% PEG 4000",
    "24-34% PEG 4000 200MM SODIUM ACETATE 50MM TRIS",
    "ZNSO4+ 8 MM MES PH:6.50",
    "MGCL2 EXAHYDRATE; 0.3 M CACL2 DIHYDRATE; 25% W V PEG 3350; 25% W V MPD; 20% V V PEG 1000; 0.1 M MES IMIDAZOLE",
    "AMSO4",
    "3 UL DROPS THAT WERE FORMED BY ADDING 1 UL OF PURIFIED SARS-3CLPRO (10 MG ML) THAT HAD BEEN INCUBATED FOR THREE HOURS WITH A 3 MOLAR EXCESS OF THE OF COMPOUND X77",
    "ZINC ACETATE 20% (W V) PEG 3350",
    "PET3350",
    "MUTANT",
    "RESERVOIR CONTAINED 0.2 M SODIUM ACETATE",
    "PROTEIN CONCENTRATION 4 MG ML. 0.2 M AMMONIUM CITRATE AND 12% (V V) PEG3350.",
    "17-23 % PEG 3350",
    "MMT",
    "LITHIUM CHLORIDE 0.1 M TRIS: HCL",
    "SALT: 0.15M AMMONIUM ACETATE",
    "MORPHEUS HT SCREEN (MOLECULAR DIMENSIONS",
    "SALT: 0.17M AMMONIUM ACETATE BUFFER: 0.085M SODIUM CITRATE TRIBASIC DIHYDRATE",
    "CRYSTALLIZATION: 0.01 M LI2SO4 MONOHYDRATE",
    "CRYSTALLIZATION: 0.2 M POTASSIUM FORMATE",
    "HERG3 PAS DOMAIN (15 MG ML",
    "CRYSTALS GROWN WITH 17 MG ML PROTEIN IN THE PRESENCE OF 1 MM NOVOBIOCIN AGAINST 100 MM ZINC CHLORIDE",
    "W V NACL",
    "W V NAK TARTRATE",
    "PROTEIN WAS CRYSTALLIZED IN SD2 PLATES SET BY A MOSQUITO CRYSTALLIZATION ROBOT. THE HIT CAME FROM PACT PREMIERE SCREEN A7",
    "CRYSTALS WERE SET WITH A MOSQUITO INTO SD2 PLATES. THE CONDITION THAT PROVIDED THE CRYSTALS FOR THIS DATA SET CAME FROM MORPHEUS SCREEN D9: 10% ALCOHOLS",
    "200 NL 7 MG ML PROTEIN + 200 NL RESERVOIR SOLUTION (2.5-2.8 M AMMONIUM SULFATE",
    "THE SARS-3CLPRO:47 A INHIBITOR COMPLEX WERE CO-CRYSTALLIZED USING THE HANGING-DROP",
    "SODIUM FORMATE AND 20% POLYETHYLENE GLYCOL 3350",
    "30%W V PEG3350",
    "ZCD2 PROTEIN",
    "CACODYLATE HCL",
    "W V MMW PGSM",
    "SSODIUM CITRATE",
    "1.8-2.4 M AMMONIUM SULFATE",
    "CRYSTALS FORMED BY MIXING 1:1 RATIO OF 13.3 MG ML PROTEIN SOLUTION WITH WELL SOLUTION CONTAINING 100 MM 4-(2-HYDROXYETHYL)-1-PIPERAZINEPROPANESULFONIC ACID (HEPPS)",
    "WELL SOLUTION: 200 MM AMMONIUM PHOSPHATE",
    "PEG 2000MME",
    "22-27% POLYETHYLENE GLYCOL (PEG) 3350 AND 0.2 M MAGNESIUM FORMATE",
    "22-27% PEG 3350 AND 0.2 M MAGNESIUM FORMATE",
    "BIS-TRIS.CL AT",
    "LEPNA.00116.A.B1.PS38420 [BARCODE: 314605H9",
    "PA200 0.1 M NAOAC 0.2 M NACL",
    "OF PEG 3350 IN 50MM PHOSPHATE BUFFER AT",
    "NAPO4",
    "CAPS NAOH",
    "0.18 TO 2.3M (NH4)2SO4 AND 0.10 M TRISHCL",
    "LITHIUM SULPHATE 0.1M ACETATE",
    "LITHIUM SULPHATE 0.1M SODIUM CITRATE",
    "0.1-0.15M AMMONIUM SULFATE 0.1 M BIS-TRIS",
    "20%PEG 8000",
    "LYSOZYME SAMPLE (14 MG ML) IN 2.5 MM HEPES",
    "PEG10000",
    "FGGS",
    "PRECIPITANT: 10.0 %W V (8.0 UL OF STOCK 50.0 %W V) PEG 6000; BUFFER: 0.1 M (4.0 UL OF STOCK 1.0 M) MES (",
    "SODIUM FORMATE 18% PEG3350",
    "PRECIPITANT: PEG4000 (25%-35% W V)",
    "BIT-TRIS",
    "PRECIPITANT: 30% PEG4000",
    "NAA50 APO PROTEIN (13.0 MG ML) WAS INCUBATED WITH 4A AND ACCOA IN A 1:3:3 MOLAR RATIO ON ICE FOR 60 MIN. RESERVOIR SOLUTION CONTAINING 0.1 M BIS_TRIS",
    "SODIUM CITRATE AND 50MM TRIS AT",
    "1.0-1.5M SODIUM CHLORIDE",
    "PROTEIN AND PEPTIDE WERE MIXED AT A 1:2 MOLAR STOICHIOMETRY WITH A FINAL PROTEIN CONCENTRATION OF 12 MG ML IN CRYSTALLIZATION BUFFER. THIS WAS USED DURING HANGING-DROP CRYSTALLIZATION IN A 1:1 RATIO WITH 0.1 M HEPES",
    "TRIS-HCL 1.6 M SODIUM CITRATE",
    "TRIS-HCL 1.6 M SODIUM CITRAT",
    "VVTOXRP",
    "NABR",
    "AMMONIUM SULPHATE AND 0.1M TRIS",
    "TRIS 0.1M",
    "2-2.5M SODIUM ACETATE",
    "WELL CONDITION: 0.3 M MAGNESIUM FORMATE PLUS 0.1 M TRISHCL. PROTEIN: THE INSULIN ANALOG WAS PREPARED IN A MIXTURE THAT ALSO CONTAINED RECEPTOR FRAGMENTS: 5 MG ML (IR310.T).FV83-7 IN 10MM HEPES-NAOH (",
    "SODIUM CITRATE 0.1 M TRIS-HCL",
    "SODIUM MALONATE AT",
    "1.4 TO 2 M AMMONIUM SULFATE",
    "25-26% PEG3350",
    "28-41% PEG3350",
    "PROTEIN SOLUTION: 10 MG ML IN 10 MM HEPES",
    "USING FILTERED CULTURE MEDIA WITH ACTIVE FUNGAL CELLS AS THE STOCK PROTEIN SOLUTION",
    "SODIUM ACETATE 0.1 M SODIUM CHLORIDE 1.5 M",
    "PEG20000 8% PEGMME 550 0.1 M SODIUM ACETATE 0.2 M MAGNESIUM CHLORIDE",
    "PEG3350 4% ISOPROPANOL 0.1 M CALCIUM CHLORIDE 0.1 M HEPES",
    "LITHIUM SULFATE 1.4 M 2% PEG400 TRIS 0.1 M",
    "AMMONIUM SULFATE 5% DIOXANE 0.1 M MES",
    "MES 0.1 M 20% PEG6000 LITHIUM CHLORIDE 0.2 M",
    "1.1-1.4 M AMMONIUM SULFATE",
    "PEG 4K 0.2 M LITHIUM SULFATE 50 MM TRIS",
    "CRYSTALLIZATION CONDITION: PROTEIN: 7.5 MG ML IN 10 MM TRIS AND 10 MM NACL MOTHER LIQUID: 0.2 M AMMONIUM ACETATE",
    "W V PEG 6000",
    "TRIS-HCL BUFFER",
    "2.0-2.2M (NH4)2SO4",
    "POTASSIUM-SODIUM TARTRATE",
    "MOTHER LIQUOR: 0.1 M MES MONOHYDRATE",
    "12 - 18% PEG 8000",
    "AMMONIUM SULFATE 0.05 M MES (",
    "NACL 0.7-1.5 M",
    "MORPHEUS SCREEN D9 (0.12M ALCOHOLS",
    "MALONIC ACID",
    "1.5 - 2.1 M AMMONIUM SULFATE",
    "COCL2",
    "NACITRATE 50MM TRIS",
    "HEPES-7.0",
    "TRIS-8.0",
    "NA CHLORIDE",
    "NA K-PHOSPHATE",
    "PEPTIDE IN 2.4 M SODIUM MALONATE",
    "PEG 3350 0.1M BIS-TRIS 0.03 MM HCL",
    "1.8 - 2.0 M AMMONIUM SULPHATE",
    "PROTEIN AT 56MG ML",
    "0.025-0.125 MM CARBOXYLIC ACID MIX",
    "PEG3350 10% ETHYLENE GLYCOL 0.2M SODIUM ACETATE",
    "PEG3350 10% ETHYLENE GLYCOL 0.2M SODIUM FLUORIDE",
    "(V V) MPD 10 MM KPI BUFFER",
    "(V V) MPD 10 MM KP",
    "100 NANOLITER COVALENTLY MODIFIED KRAS (CONCENTRATION 18.8 MG ML",
    "STMAA.01026.C.B1.PW38743 + 2 MM PLP + 2 MM ALANINE AGAINST MOLECULAR DIMENSIONS MORPHEUS SCREEN",
    "FINAL CONCENTRATIONS OF COMPONENTS: 16.6 MM SODIUM PHOSPHATE (",
    "PROTEIN 17.6 MG ML IN 0.050 M TRIS-HCL",
    "MES-NAOD (PD 7.0)",
    "CRYSTALLIZATION CONDITION: SODIUM CITRATE 1.8 M",
    "CRYSTALLIZATION BUFFER : SODIUM CITRATE 1.8 M PH=6.4",
    "NA CITRATE TRIBASIC 20% PEG3350",
    "LI ACETATE 20% PEG 3350",
    "MES: 8.5 MM ZNSO4: 19.42 % PEG MME 550: 15% GLYCEROL",
    "MES: 4 MM ZNSO4: 12.36 % PEG MME 550: 11.57 % GLYCEROL",
    "IMIDAZOLE-MALATE",
    "IMIDAZOLE MALATE 24% PEG600",
    "(V V) MPD 10 MM KP BUFFER",
    "BIS-TRIS 25 % PEG3350 0.2 M NACL",
    "HEPES 23 % PEG 6K 0.1 M LISO4",
    "TRIS 25 % PEG 4K 0.2 M CACL2",
    "NA ACETATE 30 % PEG 4K 0.2 M NH4 ACETATE",
    "RESERVOIR CONTAINED 0.1M TRI-SODIUM CITRATE",
    "RESERVOIR CONTAINED 0.1 M NA ACET 4.6 PH",
    "HEPES:NAOH",
    "POTASSIUM IODINE",
    "DILUTION OF 0.1 M LISO4",
    "OF 0.2 M MGCL2 HEXAHYDRATE",
    "PROTEIN SAMPLE: 29 MG ML TH6H IN WATER",
    "PROTEIN SAMPLE: 37.5 MG ML TH6H IN WATER. MOTHER LIQUOR: 100 MM DISODIUM 2-OXOGLUTARATE",
    "PROTEIN DISSOLVED IN 50 MM HEPES",
    "HGSTP1-1 (50 MM DIPOTASSIUM PHOSPHATE",
    "200 NL 5.9 MG ML PROTEIN + 200 NL RESERVOIR (2.7 M AMMONIUM SULFATE",
    "HCOONA",
    "8 MICROLITER DROPS WITH 5-15 MG ML PROTEIN",
    "2:1 PROTEIN:WELL SOLUTION. 0.1 M",
    "SODIUM BROMIDE",
    "M MES",
    "CACL 0.1 M SODIUMACETAT 30% PEG400",
    "THE CRYSTALLIZED SAMPLE WAS 25 MG ML MTDA SUPPLEMENTED WITH 2.5 MM METHENYL-H4MPT",
    "ALCOHOLS (1",
    "PEG-MME 2K",
    "18%W V PEG 3350",
    "18%W V PEG3350",
    "20%W V PEG 3350",
    "PROTEIN SOLUTION THAT CONTAINS 18% (W V) PEG3350",
    "PROTEIN SOLUTION THAT CONTAINS 18% (W V) PEG 3350",
    "SODIUM ACETATE TRIHYDRATE 0.1M TRIS HYDROCHLORIDE 8.5 30% W V POLYETHYLENE GLYCOL 4",
    "PEG5K MME",
    "HEPES 100MM NACL 2MM MGSO4",
    "MAGNESIUM CHLORIDE CALCIUM CHLORIDE",
    "VAPOR DIFFUSION IN SITTING DROP CRYSCHEM PLATES. RESERVOIRS WERE 1.0 M SODIUM CITRATE TITRATED WITH ACETIC ACID TO",
    "MIB BUFFER (MALONIC ACID",
    "PROTEIN SOLUTION ( 10 G L LBADH",
    "PROTEIN SOLUTION (5 G L LBADH",
    "5-20 MG ML PROTEIN IN 25MM HEPES\\ NAOH",
    "BIS-TRIS HCL",
    "PURIFIED OHRA PROTEIN 10MG ML IN 5MM TRIS-HCL",
    "PURIFIED OHR PROTEIN AT 10MG ML IN 5MM TRIS-HCL",
    "POLYETHYLENE GLYCOL 3350 AND 0.2 M LITHIUM CHLORIDE",
    "THE PROTEIN WAS DISSOLVED IN A BUFFER CONSISTING OF 50 MM TRISHCL",
    "CRYSTALS GROWN BY HANGING DROP VAPOUR DIFFUSION. A 1:1 MIXTURE OF 15MG ML PROTEIN SOLUTION AND AN 8:4 MIXTURE OF 3.0M K2HPO4 TO 1.4M KH2P04 WAS PLACED ABOVE A WELL OF AN 8:6 SOLUTION OF 3.0M K2HPO4 TO 1.4M KH2PO4. THEN SERIALLY CRYOPROTECTED IN SITU TO 40% GLYCEROL (V V WITH MOTHER LIQUOR) IN 10% INCREMENTS OVER A PERIOD OF A FEW MINUTES.",
    "CITRATE PHOSPHATE BUFFER",
    "HAMPTON RESEARCH SALT RX SCREEN",
    "POLYETHYLENE GLYCOL 8000 (PEG 8K)",
    "20-28% (M V) POLYETHYLENEGLYCOL (PEG) 3350",
    "LEPNA.01147.A.B1.PW38321 WAS CRYSTALLIZED AT 19.49 MG ML WITH 4 MM PLP",
    "AMONIUM SULFATE",
    "PROTEIN SOLUTION: 2.2 MM PROTEIN WITH 1.65 MM FE AND 2 MM ZN ADDED 1 HOUR BEFORE CRYSTALLISATION. 1 UL TO 1 UL DROPS WITH FOLLOWING MOTHER LIQUOR: 30% PEG400",
    "PS_CEL5A (27 MICROM) IN 50 MM SODIUM PHOSPHATE",
    "MGCL2 HEXAHYDRATE OR 0.2 M CACL2 DIHYDRATE",
    "(NH4)2HPO4",
    "PROTEIN SOLUTION- 60 MG ML TRYPSIN",
    "PROTEIN SOLUTION - 60 MG ML TRYPSIN",
    "SODIUM ACETATE TRIHYDRATE 20% (W V) POLYETHYLENE GLYCOL 3350",
    "KI",
    "HAMPTON RESEARCH INDEX",
    "SITTING DROP",
    "MPD_PEG1000_PEG3350 (PRECIPITANT MIX 4 MORPHEUS)",
    "MPD_PEG1000_PEG3350",
    "OF 0.1 PCTP",
    "AMMONIUM CITRATE AND 100MM HEPES",
    "SODIUM ACETATE ANHYDROUS",
    "AMMONIUM SULFATE 0.1 M SODIUM CITRATE",
    "CO ATMOSPHERE",
    "PEG 4000 AND 0.2 M (NH4)2SO4",
    "SODIUM NITRATE; 0.1M TRIS",
    "20 MICROL URATE OXIDASE (AT 20 MG ML+0.2MG ML 8-AZAXANTHINE",
    "1:1 6MG ML TERB PROTEIN 3MM POLYPORIC ACID IN 33% ISOPROPYL TO 25% PEG 3350",
    "PEG MONOMETHYL ETHER 2K",
    "RESERVOIR: 20% PEG 4000",
    "RESERVOIR: 30% PEG 2000 MME",
    "20-30% PEG 4K",
    "HDAC6 CD1 2 MM INHIBITOR 0.2 M AMMONIUM TARTRATE DIBASIC (",
    "HDAC6 CD1 2 MM INHIBITOR 0.2 M SODIUM MALONATE (",
    "HDAC6 CD1 2 MM INHIBITOR 0.2 M SODIUM PHOSPHATE DIBASIC DIHYDRIDE 20% PEG 3350 1:1 RATIO PROTEIN TO PRECIPITANT",
    "HDAC6 CD1 2 MM INHIBITOR 0.2 M MAGNESIUM FORMATE DIHYDRATE 20% PEG 3350 1:1 RATIO PROTEIN TO PRECIPITANT",
    "V V PEG3350",
    "SODIUM THIOCYANATE AND 20% (W V) PEG 3350",
    "MAGNESIUM CHLORIDE HEXAHYDRATE 0.1 M HEPES",
    "POTASSIUM SODIUM TARTRATE TETRAHYDRATE 0.1 M BIS-TRIS PROPANE",
    "SUCCINIC ACID 0.1 M HEPES",
    "0.5-1 M AMMONIUM SULFATE",
    "0.4-0.6 M AMMONIUM SULFATE",
    "W V TRYPTONE",
    "RIGAKU REAGENTS WIZARD 3 4",
    "BIS-TRIS AT",
    "BASED ON THE MORPHEUS SCREEN FROM MOLECULAR DIMENSIONS: G12 - 0.1 M CARBOXYLIC ACIDS",
    "ENZYME MIXED 50 50 WITH RESERVOIR SOLUTION CONTAINING MORPHEUS SCREEN SOLUTION C12: 0.09 M NPS (0.3M SODIUM NITRATE",
    "ENZYME MIXED 50 50 WITH RESERVOIR SOLUTION CONTAINING MORPHEUS SCREEN SOLUTION G12: 0.1 M CARBOXYLIC ACIDS (0.2M SODIUM FORMATE; 0.2M AMMONIUM ACETATE; 0.2M SODIUM CITRATE TRIBASIC DIHYDRATE; 0.2M SODIUM POTASSIUM TARTRATE TETRAHYDRATE; 0.2M SODIUM OXAMATE)",
    "100MM SODIUM CACODYLATE",
    "SODIUM CITRATE AND 0.1 M SODIUM CACODYLATE",
    "24-34% PEG 4000 200 MM SODIUM ACETATE 50 MM TRIS",
    "0.1 MAGNESIUM CHLORIDE 16%(W V) TRIS-HCL",
    "POTASSIUM BROMIDE 28%(W V) PEG2000 MME +15% GLYCEROL",
    "SODIUM CHLORIDE 0.1M HEPES",
    "24-26% PEG 3350",
    "A SOLUTION OF PROTEIN AT 1MM WAS INCUBATED WITH 5MM CELLOHEXOSE FOR 4 HOURS AT ROOM TEMPERATURE. THE MIXTURE WAS SCREENED USING A TTP LABTECH MOSQUITO AND MRC SD-2 PLATES 200 NL PROTEIN 200 NL RESERVOIR",
    "MOPS HEPES-NA",
    "PEG8K",
    "6%PEG3350",
    "PROMIROLYSIN CRYSTALS WERE OBTAINED AT 20 DEGREES FROM DROPS CONTAINING 200 NL OF PROTEIN SOLUTION AT 0.6 MG ML IN 5 MM TRIS-HCL",
    "PEG3350 W V",
    "THE CRYSTALLIZATION SOLUTION CONTAINED 1 UL OF 2 MM OLIGONUCLEOTIDE AND 6 UL OF A SOLUTION CONTAINING 10% (V V) 2-METHYL-2",
    "PROTEIN: 7.12 MG ML",
    "OF TRI-SODIUM CITRATE (",
    "MAGNESIUM CHLORIDE AND 20 % (W V) PEG 3350",
    "PEG 3350 0.2 M NANO3",
    "ETHYLENE GLYCOL (V V)",
    "MYTUD.00554.A.B1.PW38579 AT 23.33 MG ML WAS INCUBATED WITH 5 MM NAD",
    "ACCAA.00032.A.B1.PW38645 AT 20.81 MG ML",
    "SODIUM CITRATE TRIBASIC",
    "PROTEIN DROP: 75 MG ML PROTEIN IN 45% DMSO 0.5 M ZNCL2",
    "DROP: 75 MG ML PROTEIN IN 45% DMSO 0.5 ZNCL2",
    "SVQIVY",
    "MIX OF ETHYLENE GLYCOLS 0.1 M TRIS (BASE) BICINE 30% W V PEG MME550 30% W V PEG 20",
    "ISO-PROPANOL",
    "TRI-SODIUM CITRATE DIHYDRATE (",
    "15-20% POLYETHYLENE GLYCOL (PEG) 8000",
    "POTASSIUM PHOSPHATE (DIBASIC)",
    "POTASSIUM PHOSPHATE (DI BASIC)",
    "15-20% PEG 8000",
    "CRYSTALLIZATION BUFFER WAS 0.1M SODIUM BICINE (",
    "AMINO ACID STOCK (0.2M L-NA-GLUTAMATE; 0.2M ALANANINE (RACEMIC); 0.2M GLYCINE; 0.2M LYSINE HCL (RACEMIC); 0.2M SERINE (RACEMIC)",
    "MIB [MALONIC ACID",
    "PEG 2000 MME 150 MM POTASSIUM BROMIDE",
    "V V POLYETHYLENE GLYCOL 8000",
    "NACL 0.1M MES",
    "20-25% PEG3350",
    "PROTEIN SOLUTION: 5 MG ML PROTEIN",
    "PROTEIN SOLUTION: 4.2 MG ML PROTEIN",
    "HEPES MOPS",
    "DROP RATIO 1:1 PROTEIN: 100 MG ML IN 10 MM MES",
    "NACITRATE 50 MM HEPES 7.5 14MG ML PROTEIN",
    "PEG 3350 AND 200 MM POTASSIUM NITRATE",
    "AMMONIUM SULFATE D-8",
    "TRIS 8.0",
    "PEG 1500 (W V)",
    "POLY ETHYLENE GLYCOL 3350",
    "CRYSTALLIZATION OF [FE]-HYDROGENASE-METHENYL-H4MPT+ COMPLEX WAS PERFORMED IN THE ANAEROBIC TENT WITH GAS PHASE 100%N2 AT ROOM TEMPERATURE UNDER DARK CONDITION. THE RECONSTITUTED [FE]-HYDROGENASE HOLOENZYME (50 MG ML) WAS MIXED WITH 10 MM METHENYL-H4MPT+",
    "CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM THIOCYANATE",
    "D-AMMONIUM SULFATE",
    "RESERVOIR MIXTURE OF 13.5-15 % PEG 6000 (W V)",
    "13.5-15% PEG6000 (W V) 4% PEG400 (V V) 2% GLYCEROL (V V)",
    "250 NL 7.5 MG ML PROTEIN + 225 NL WELL SOLUTION (2.5-3.0 M AMMONIUM SULFATE",
    "POTASSIUM PHOSPHATE MONOBASIC AND 20% W V PEG 8",
    "SOAKING OF CRYSTALS GENERATED IN 2% PEG 400",
    "PEG 6000 AND 2M NACL",
    "NACL AND 10% ETHANOL",
    "OF PURIFIED CYTOCHROME (1 MM HEPES",
    "TO 0.2 M (NH4)2SO4",
    "SODIUM CACODYLATE 30% W V POLYETHYLENE GLYCOL 8000",
    "HEPES SODIUM 1 M LITHIUM SULFATE MONOHYDRATE",
    "SODIUM ACETATE TRIHYDRATE. 0.1 M SODIUM CACODYLATE TRIHYDRATE",
    "PEG 6K",
    "(W V) PEG-400",
    "HEPES 10% W V PEG 8000 8% V V ETHYLENE GLYCOL",
    "HEPES 10% W V PEG 6000",
    "PEG 6000 20% W V HEPES 0.1 M DMSO 5%",
    "BS1",
    "PEG550MME",
    "PEG6000 10% ETHYLENE GLYCOL 0.2M LITHIUM CHLORIDE",
    "TRYPTONE",
    "PROTEIN: 5.2 MG ML",
    "MPD 20% IPA 25 MM SODIUM ACETATE",
    "MPD 20% IPA 25 MM SODIUM ACETATE BUFFER",
    "BICINE-NAOH",
    "15.00 %W V PEG 3350",
    "8-12% PEG 3350",
    "PEG20000 MME",
    "OF COP1 SUPPLEMENTED WITH 3 TO 10 FOLD MOLAR EXCESS IN PEPTIDE WAS MIXED WITH TWO-FOLD (V V) MORE MOTHER LIQUOR (1:2 RATIO; PROTEIN:BUFFER) CONTAINING 2 M (NH4)2SO4 AND 0.1 M HEPES",
    "OF COP1 SUPPLEMENTED WITH 3 TO 10 FOLD MOLAR EXCESS IN PEPTIDE WAS MIXED WITH TWO-FOLD (V V) MORE MOTHER LIQUOR (1:2 RATIO; PROTEIN:BUFFER) CONTAINING 1.25 M SODIUM MALONATE",
    "BETWEEN AND 10-15 MG ML OF PROTEIN MIXED WITH 1.5 M AMMONIUM SULFATE",
    "W V PEG400",
    "0.2-0.4M MG-FORMATE 0.1M BISTRIS BUFFER",
    "W V PEG 400",
    "MORPHEUS BUFFER 3",
    "RESERVOIR CONTAINED 0.1 M KSCN",
    "- 4 % PEG400 45 % - 55% AMMONIUM SULFATE 0.1 M HEPES",
    "AMMONIUM SULFATE -- 0.1M CITRATE",
    "TASCIMATE 0.1M BIS-TRIS PROPANE",
    "TASCIMATE",
    "NAH2PO4 0.91 M K2HPO4",
    "D(TCGGCGCCGA)2",
    "MPD 10% PEG8000 0.1M HEPES",
    "RESERVOIR CONTAINED 0.1 M SODIUM ACETATE",
    "PEG 1000 10 % PEG 8000",
    "SODIUM CHLORIDE AND 0.1M SODIUM ACETATE",
    "6-9% NACL ET 0.1M NA ACETATE",
    "6-9% NACL",
    "12-17 % PEG8000 0.2 M CALCIUM ACETATE 0.1 M MES",
    "STANDARD HEN EGG WHITE LYSOZYME (20 MG) CRYSTALLISATION CONDITIONS WERE USED OF 10% NACL",
    "NACL 12% PEG 6K",
    "(NH 4 ) 2 SO 4 3% ISO-PROPANOL AND 0.1M SODIUM CITRATE",
    "LI2SO4 0.1M TRIS",
    "KF AND 14% PEG3350",
    "SODIUM MALONATE (",
    "200 NL 7 MG ML PROTEIN + 200 NL RESERVOIR (50 MM TRIS",
    "1.5 MICROL 12 MG PER ML RPPEP-1 E143A Y178F WITH 6 MM SUBSTRATE PEPTIDE IN 20 MM TRIS",
    "1.5 MICROL 12 MG PER ML RPPEP-1 E143A Y178F WITH 6 MM SUBSTRATE PEPTIDE (AC-EVNPAVP-CONH2) IN 20 MM TRIS",
    "1 MICROL 12 MG PER ML RPPEP-1 E143A Y178F WITH 6 MM SUBSTRATE PEPTIDE (AC-EVNPPVP-CONH2) IN 20 MM TRIS",
    "1.5 MICROL 12 MG PER ML RPPEP-1 E184A IN 20 MM TRIS",
    "1.5 MICROL 12 MG PER ML RPPEP-1 E184K IN 20 MM TRIS",
    "4 MICROL 12 MG PER ML RPPEP-1 W103F IN 20 MM TRIS",
    "PBS SUPPLEMENTED WITH 300 MM D-RIBOSE. CRYOPROTECTION: 25 % (W V) PEG 400",
    "10 - 25 % PEG 2K OR 3K 0.1 M NA ACETATE OR CITRATE 0.1 M NH4CL",
    "PEG2000 MONOMETHYL ETHER",
    "NAH2PO4.H2O 0.14 M K2HPO4",
    "THE PROTEIN WAS CONCENTRATED TO 20 MG ML IN 100 MM TRIS",
    "15~20% PEG 3350",
    "1.6-2.0 M MGCL2 AND 0.1 M BICINE",
    "SODIUM ACETATE BUFFER (",
    "AMMONIUM N-[TRIS(HYDROXYMETHYL)METHYL]-2-AMINOETHANNE SULFONATE",
    "POTASSIUM SODIUM TARTRATE TETRAHYDRATE 20% W V PEG 3350.",
    "AMMONIUM CITRATE TRIBASIC (",
    "RESERVOIR: 0.1M TRIS-HCL (",
    "W V PEG 5000 MME",
    "SODIUM CACODYLATE (PH = 7.2)",
    "1.5 UL OF PROTEIN SOLUTION (8 MG ML IN THE BUFFER 10 MM HEPES",
    "SODIUM ACETATE: HCL",
    "TRYPTONE CM1(A6) 1% TRYPTONE",
    "PROTEIN 25 MG ML",
    "COMPLEX WAS PREPARED BY ADDING 1-FOLD MOLAR EXCESS OF INHIBITOR (DISSOLVED IN PURE DMSO) TO 25 MG ML PROTEIN SOLUTION IN WATER. 2 UL OF COMPLEX SOLUTION WERE MIXED WITH 1 UL OF PRECIPITANT SOLUTION CONTAINING 1.6M SODIUM CITRATE",
    "MGCL2. 0.1 M NA CACODYLATE",
    "DI-SODIUM TARTRATE AND 20% W V PEG 3350",
    "NA KPO4",
    "PROTEIN WAS 10 MG ML IN 0.1% BETA-MERCAPTOETHANOL",
    "CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION (12MG ML",
    "HEPES. 25% PEG 3000",
    "DROP CONSISTS OF 2 UL OF 25% PEG 3350",
    "DROP CONSISTS OF 2 UL OF 30% PEG 400",
    "DROP CONSISTS OF 2 UL OF 25% PEG 1500",
    "NABR; 0.1 M BIS TRIS PROPANE",
    "TRIS-HCL BUFFER (",
    "1.0-1.4 M NA K PHOSPHATE",
    "COCRYSTAL WITH 1.2M AMMONIUM SULFATE",
    "PEG6K WITH 0.1M MES",
    "MANGANESE ACETATE AND 2% (V V) PEG 3350",
    "TRIS 8.5 20 % V V GLYCEROL ETHOXYLATE",
    "SODIUM CITRATE TRIBASIC DIHYDRATE AND 100 MM BIS-TRIS PROPANE (PH=8.5)",
    "PEG 3350 0.5 M KH2PO4 PROTEIN AND INHIBITOR WERE MIXED IN RATIO 1:1.5 1 UL OF PROTEIN:INHIBITOR COMPLEX WAS MIXED WITH 1 UL MOTHER LIQUOR",
    "PEG 3350 0.5 M KH2PO4 PROTEIN AND INHIBITOR WERE MIXED IN RATIO 1:3 1 UL OF PROTEIN:INHIBITOR COMPLEX WAS MIXED WITH 1 UL MOTHER LIQUOR",
    "PEG 3350 0.5 M KH2PO4 PROTEIN AND INHIBITOR WERE MIXED IN RATIO 1:2 1 UL OF PROTEIN:INHIBITOR COMPLEX WAS MIXED WITH 1 UL MOTHER LIQUOR",
    "PEG 3350 0.5 M KH2PO4 1 MM NACL PROTEIN AND INHIBITOR WERE MIXED IN RATIO 1:2 1 UL OF PROTEIN:INHIBITOR COMPLEX WAS MIXED WITH 1 UL MOTHER LIQUOR",
    "PROTEINASE K WAS DISSOLVED IN 10 MM CALCIUM CHLORIDE",
    "PROTEIN IN BUFFER: 20 MM HEPES",
    "PEG6000 0.2 M CALCIUM CHLORIDE 0.1 M MES",
    "NH4CL AND 20%W V PEG 3350",
    "PEG 8",
    "TRIS; O.2 M NAAC",
    "100 NL MOTHER LIQUOR   200 NL PROTEIN 15% GLYCEROL",
    "(NH4)2SO2 AND 50MM HEPES BUFFER",
    "W V PEG4000",
    "HEPES-KOH",
    "A RACEMIC MIXTURE OF L-LACTICIN Q AND D-LACTICIN Q AT 27 MG ML CONCENTRATION WAS MIXED 1:1 WITH 4.0M SODIUM FORMATE PRECIPITANT CONDITION",
    "JCSG+ D12: 16% (W V) PEG 8000; 20% (V V) GLYCEROL",
    "MIB 8.0 25 % W V PEG 1500 (B5 CONDITION PACT PREMIER PLATE)",
    "SODIUM CITRATE 0.1 M BIS TRIS PROPANE 7.5 20 % W V PEG 3350",
    "INDEX CONDITION F5 (0.1 M AMMONIUM ACETATE",
    "PEG 1500 AND 0.1 M TBG BUFFER",
    "PEG 6K; 15% PEG 400; 0.2M MGCL2 IN 0.1 TRIS-HCL",
    "PEG4K 10 MM SODIUM CITRATE",
    "TO 1.2 M NA ACETATE AND 0.1 M HEPES FROM",
    "PROTEIN SOLUTION AT 130 MG ML IN 20 MM TRIS-HCL",
    "PLECTASIN IN 10 MM HIS",
    "PEG3350 0.2 M AMMONIUM CITRATE",
    "BT3177S1_11 WITH 10 MM 6S-GLCNAC CRYSTALLISED IN 50 % PRECIPITANT MIX 1 (40% V V PEG 500",
    "BT4631 WITH 10 MM 6S-GAL WAS CRYSTALLISED IN 20 % PEG 10K AND 0.1 M BICINE",
    "1:1 RATIO OF 7.2 MG ML PROTEIN WITH 0.1M CITRIC ACID",
    "PEG 3000 15%",
    "PROTEIN IN 0.1 M NAOAC (",
    "6%TACSIMATE",
    "LYSOZYME-INHIBITOR COMPLEX [20 MG ML LYSOZYME PLUS 10 MG ML N",
    "IN 50 MM SODIUM ACETATE (",
    "AMMONIUM SULFATE; 0.1 M CITRIC ACID",
    "KF",
    "BIS-TRIS 24% (W V) PEG 3350",
    "PEG 4000 10 MM SODIUM CITRATE",
    "PEG 6000 140 MM NACL 0.1M NAACETATE",
    "DROPLETS WERE 200 NL PROTEIN AT 10 MG ML PLUS 200 NL RESERVOIR",
    "THE PROTEIN AT 10 MG ML WAS SET UP IN 200 PLUS 200 NL DROPS WITH THE RESERVOIR AS 20% (W V) PEG 3350 AND 0.2 M MAGNESIUM ACETATE",
    "MAGNESIUM SULFATE HEPTAHYDRATE 0.1M MES",
    "NAPO4 NA2HPO4",
    "160 NL OF PROTEIN (3.25 MM) IN 20 MM TRIS",
    "160 NL OF PROTEIN (2.15 MM) IN 20 MM TRIS",
    "160 NL OF PROTEIN (0.6 MM) IN 20 MM TRIS",
    "SPG BUFFER NAOH",
    "IN 20 MM TRIS-HCL",
    "4-8% (M V) NACL IN 0.1 M ACETATE BUFFER",
    "(M V) PEG8000; 0.1 M IMIDAZOLE",
    "PEG4K; 0.2 M AMMONIUM SULFATE",
    "AS",
    "(W V) PEG 4000",
    "PROTEIN: 5 MG ML TTR DIALYSED AGAINST 0.1 M NACL",
    "85-90MM HEPES",
    "1.4-1.6 M (NH4)2SO4",
    "PEG 3350 0.19 M AMMONIUM CITRATE DIBASIC 0.02 M SODIUM CITRATE TRIBASIC DIHYDRATE",
    "0.8-1.2 M SODIUM CITRATE TRIBASIC DIHYDRATE",
    "SCREEN: 0.2 M AMMONIUM ACETATE",
    "SCREEN CONDITION: 0.2 M AMMONIUM ACETATE",
    "POTASSIUM THIOCYANATE 20% PEG 3350 10MM MNCL2 2MM DGTP",
    "AMMONIUM SULPHATE; 0.01 M CADMIUM CHLORIDE HEMI (PENTAHYDRATE); 0.1 M PIPES (",
    "55-60 % MPD AND 0.1 M SPG BUFFER",
    "OF INDEX G12 (0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE 0.1 M HEPES",
    "(SODIUM MALONATE DIBASIC MONOHYDRATE",
    "(0.2M 1",
    "TRIS-HCL BUFFER AT",
    "CITRIC ACID NAOH (",
    "IMIDAZOLE HCL (",
    "CRYSTALLIZATION SOLUTION: 100MM MES",
    "W V POLYETHYLENE GLYCOL 3350",
    "DI-SODIUM DL-MALATE",
    "15-25MG ML HEWL",
    "XYLOSE",
    "ACETYLATED XYLOOLIGOSACCHARIDES",
    "SODIUM ACETATE 0.2 M AMMONIUM SULFATE 3 % PEG2000",
    "IMIDAZOLE.HCL",
    "POLYETHYLENE GLYCOL (PEG) 6000",
    "NIKE(II) CHLORIDE HEXAHYDRATE",
    "PEG 20K",
    "PEG",
    "MORPHOLINOETHANE SULPHONIC ACID (",
    "8 - 12% POLY(ETHYLENE GLYCOL) 8000",
    "ADK AT 18.3 MG ML WAS MIXED WITH 5 MM EACH OF AMP AND GTP IN 30 MM MOPS BUFFER",
    "1.5-1.7 M SODIUM CITRATE",
    "PROTEIN AT 8MG ML 0.12 M MONOSACCHARIDES (0.2 M D GLUCOSE; 0.2 M D MANNOSE; 0.2 M D GALACTOSE; 0.2 M L FUCOSE; 0.2M D XYLOSE; 0.2 M N ACETYL D GLUCOSAMINE)",
    "30% W V PEG 2000 MONOMETHYL ETHER AND 0.1 M POTASSIUM THIOCYANATE",
    "AFTER 1:1 DILUTION WITH THE PEPTIDE SOLUTION",
    "PROTEIN IN DEIONISED WATER IS MIXED AT EQUAL VOLUME WITH 52% MPD.",
    "ZINC ACETATE AND 20 % W V PEG3350",
    "RESERVOIR: 0.1M TRIS",
    "W V POLYETHYLENE GLYCOL 400; 100 MM MES",
    "SODIUM CITRATE HCL",
    "CRYSTALLIZATION: 100 MM TRIS HCL",
    "100 NL PROTEIN (8.3 MG ML",
    "30%-36% PEG 3350",
    "20-25%PEG3350",
    "NA K TARTRATE (W V)",
    "LYSOZYME WAS DISSOLVED IN 0.1 M SODIUM ACETATE",
    "PROTEINASE K WAS DISSOLVED AT A FINAL CONCENTRATION OF 30 MG ML IN 10MM CALCIUM CHLORIDE",
    "BICINE-CSOH",
    "20-30% PEG 3350",
    "ETOH",
    "POLYETHYLENGLYCOL (PEG) 6000",
    "PEG 3350 AND 0.2M TRI-SODIUM CITRATE",
    "PEG3350 AND 0.2M POTASSIUM-SODIUM TARTARATE",
    "MCSG1 CONDITION D4: 0.2 M SODIUM THIOCYANATE",
    "WIZARD 3 4 CONDITION G1: 0.15 M POTASSIUM BROMIDE",
    "MCSG3 D4: 200MM NACL",
    "JCSG+ E1 (284863E1): 1000 MM SODIUM CITRATE DIBASIC TRIHYDRATE",
    "PACT C7 (292926C7): 200MM SODIUM CHLORIDE",
    "MCSG4 F7 (295168F7): 200MM MAGNESIUM CHLORIDE",
    "MCSG4 F7 (295174F7): 200MM MAGNESIUM CHLORIDE",
    "AMMONIUM SULFATE (DIBASIC)",
    "DI-SODIUM TARTRATE",
    "CRYSTALS OF TIM3.18 HTIM3 IGV WERE GROWN IN HANGING DROPS AT 22C CONTAINING 1 UL PROTEIN AND 1 UL WELL SOLUTION CONSISTING OF OPTIMIZED CONDITIONS OF 0.1M MES",
    "PROTEIN 23% PEG SMEAR BROAD",
    "PROTEIN CONCENTRATION WAS 4 MG ML; EQUAL VOLUMES (250 NL) OF PROTEIN PLUS RESERVOIR WERE ADDED TO THE PLATE; THE RESERVOIR WAS 1.5 M TRI-POTASSIUM CITRATE",
    "MORPHEUS C5: 12% (V V) PEG 500 MME: 8% (W V) PEG 20000",
    "MORPHEUS B5: 12% (V V) PEG 500 MME: 8% (W V) PEG 20000",
    "25%W V PEG 3350",
    "TO 30% PEG 6000",
    "1.9-2.0M AMMONIUM SULFATE",
    "AMMONIUM ACETATE 0.1 M BIS-TRIS",
    "CESIUM SULFATE AND 2.2 M AMMONIUM SULFATE",
    "V V PEG SMEAR HIGH",
    "PKA IN 100 MM MES-BIS-TRIS-BUFFER",
    "TRIS DCL",
    "AMMONIUM CITRATE (",
    "CRYSTALLIZATION BUFFER: 0.1 M TRIS-HCL (",
    "PROTEIN: 6.0 MG ML",
    "SODIUM PHOSPHATE MONOBASIC MONOHYDRATE AND 1.344 M POTASSIUM PHOSPHATE",
    "ETHYLENE GLYCOLS",
    "PEG500MME AND 0.1M SODIUM CITRATE",
    "PEG 4K 10 MM SODIUM CITRATE",
    "(0.3M MAGNESIUM CHLORIDE HEXAHYDRATE",
    "PSAEA.17999.A.B1.PW38913 AT 19 MG ML",
    "PROTEIN DNA RATIO 1:1.4",
    "PROTEIN DNA RATIO 1:2.4",
    "PROTEIN SOLUTION: 25MG ML IN 25MM TRIS",
    "PEG 4000 0.1 M HEPES BUFFER",
    "ACBAC.18888.A.B1.PW38910 AT 13 MG ML WAS MIXED 1:1 (0.4 UL PROTEIN AND 0.4 UL PRECIPITANT) WITH 0.02M CALCIUM CHLORIDE DIHYDRATE",
    "PHOSPHATE CITRATE 20 % W V PEG 6K",
    "PROTEIN: 8.8 MG ML",
    "5 %GLYCEROL",
    "14-20 % (W V) PEG 3350",
    "AMSO4 + 0.1 M BICINE",
    "POTASSIUM SODIUM TARTRATE TETRAHYDRATE 100MM NA HEPES",
    "TRISODIUM CITRATE DIHYDRATE",
    "PROTEIN SOLUTION: 8MG ML PROTEIN 20 MM SODIUM CACODYLATE",
    "PROTEIN: 7.2 MG ML",
    "PEG-3340",
    "LISO4 0.1 M MES",
    "PHOSHATE CITRATE",
    "PROTEIN AT 8 MG ML; 25% PEG 3350",
    "AMMONIUM CITRATE AND 12% PEG-3350",
    "POTASSIUM SULFATE AND 20% PEG-3350",
    "250 MICROL RESERVOIR (30% MPD",
    "TACSIMATE (1.83 M MALONIC ACID",
    "CRYSTALS WERE GROWN FROM A 10 MG ML FROZEN PROTEIN SOLUTION BY THE HANGING DROP METHOD AT 291-293K",
    "MOPSO BIS-TRIS",
    "(NH4)2SO4 40 MM GLYCINE",
    "CO-CRYSTALLIZATION",
    "PROTEIN WAS CONCENTRATED TO 16 MG ML IN 10 MM POTASSIUM PHOSPHATE. CRYSTALS GREW FROM HANGING-DROP VAPOUR DIFFUSION EXPERIMENTS USING 13% PEG 3350",
    "ETHYLENE GLYCOL 0.1 M SODIUM ACETATE BUFFER",
    "2:1 DROP RATIO 0.1 M CHES (",
    "SODIUM DIHYDROGEN PHOSPHATE MONOHYDRATE",
    "N-OCTYL-BETA-D-GLUCOSIDE",
    "CALCIUM CHLORIDE DIHYDRATE 0.1 M MES 6.0 20 % W V PEG 6000",
    "TRIS 100MM - PEG 4K 23% - NA ACET 100MM -",
    "BENZAMIDINE HYDROCHLORIDE",
    "1.6-2 M MGCL2 6H2O AND 0.1 M BICINE",
    "AMMONIUM ACETATE 0.1 M BISTRIS",
    "AMMONIUM CITRATE 20% PEG 3350 10% MORPHEUS ADDITIVE SCREEN",
    "BATCH MICROCRYSTALLIZATION WAS USED",
    "CAL PDZ",
    "MTGLNK2 WAS CRYSTALLIZED AT A CONCENTRATION OF 30 MG ML IN 25 MM TRIS HCL",
    "GLNK1 WAS CRYSTALLIZED AT 11.2 MG ML IN 25 MM TRIS HCL",
    "W V PEG1500",
    "30%W V PEG 4K",
    "MALEIC ACID",
    "SODIUM MALONATE DIBASIC",
    "SODIUM PHOSPHATE MONOBASIC 1600MM POTTASIUM PHOSPHATE DIBASIC",
    "PACT PREMIERTM 100 MM MMT BUFFER",
    "SITTING DROP CRYSTALLIZATION USING CRYSCHEM PLATES. DROPS WERE EQUAL AMOUNTS OF A 25 MG   ML PROTEIN STOCK SOLUTION IN WATER AND THE RESERVOIR SOLUTION. THE RESERVOIR WAS 1.4 M SODIUM CITRATE AT",
    "AMMONIUM PHOSPHATE DIBASIC 20% W V POLYETHYLENE GLYCOL 3",
    "DL-MALIC ACID AND 20% PEG 3350",
    "CITRATE (",
    "20 %W V PEG 3350 (POLYMER) 0.2 M CA(OAC)2 (SALT)",
    "BIS-TRIS AND 25% PEG 4000",
    "16-20% PEG-3350",
    "11-18% PEG-3350",
    "PEG-5000",
    "11-16% PEG-3350",
    "PEG500 MME",
    "TOTAL PEG CONCENTRATION",
    "TACSIMATE (HAMPTON RESEARCH)",
    "BISTRIS PROPANE",
    "PEG 3350 0.1 M BIS-TRIS",
    "24%-35% (PEG 4000 PEG 6000)",
    "24-35% PEG 4000 6000",
    "LI2SO4; 1.26 M (NH4)2SO4; 100 MM TRIS",
    "1.5 AMMONIUM SULFATE",
    "2.0 AMMONIUM SULFATE",
    "1 AMMONIUM SULFATE",
    "AMMOMIUM SULFATE",
    "BETA-CYCLODEXTRIN",
    "PEG300",
    "PROTEIN AT 5.9 MG ML; 200 NL PLUS 200 NL DROPS WITH THE RESERVOIR BEING 2.7 M AMMONIUM SULFATE AND 50 MM TRIS BUFFER AT",
    "0.2 N NACL",
    "AMMONIUM SULFATE 0.1 M HEPES 7.5 30 % V V (+ -)-2-METHYL-2",
    "PHOSPHATE CITRATE BUFFER AT",
    "NA ACET",
    "MES:",
    "AMMONIUM SULPHATE 0.1 M SODIUM CITRIC",
    "NACL 1.5 M",
    "BES BUFFER",
    "(NH4)2SO4 0.1% IMIDAZOLE 22% PEG 8000 0.1% NAN3",
    "DIVALENTS",
    "AMMONIUM SULFATE 2% PEG400",
    "0.3 MICOR-L PROTEIN (NLYSX-CMP7 [AC-(GLYPROHYP)3-GLYNLYSHYP-(GLYPROHYP)3]) IN WATER AT 5 MG ML",
    "0.3 MICRO-L PROTEIN (NLYSX-CMP7 [AC-(GLYPROHYP)3-GLYNPHEHYP-(GLYPROHYP)3]) IN WATER AT 10 MG ML",
    "SODIUM ACETATE PH: 4.6 IN 40% PEG 200",
    "MAGNESIUM CHLORIDE HEXAHYDRATE 0.1 M TRIS",
    "CRYSTALS WERE OBTAINED BY INITIAL SCREENING AT 20 DEGREE CELSIUS USING THE SITTING DROP METHOD ON A 96-WELL MRC 2-DROP CRYSTALLIZATION PLATES IN POLYSTYRENE (SWISSCI). THE CRYSTALLIZATION RESERVOIR CONTAINED 90 UL OF MOTHER LIQUOR",
    "PROTEIN SOLUTION OF 11.3 MG.ML-1 CONCENTRATION. DROPS OF 2 MICRO-L VOLUME OF THIS PROTEIN SOLUTION WERE MIXED WITH 1 MICRO-L OF CRYSTALLIZATION SOLUTION THAT CONTAINED 2.1 M DL-MALIC ACID",
    "AMMONIUM SULFATE AND 0.1 M SODIUM ACETATE",
    "DISODIUM SUCCINATE",
    "MPRO WAS THAWED AND DILUTED TO 6 MG ML USING 20 MM HEPES",
    "PEG-400",
    "AMMONIUM SULFATE IN 100 MM TRIS-HCL",
    "MICROLYTIC MORPHEUS SCREEN",
    "2 3 OF THE INITIAL CRYSTALLIZATION CONDITIONS (CHES",
    "PEG 3350 5.5-6.5",
    "MGCL2 X 6H2O",
    "CRYSTALS WERE GROWN USING THE VAPOR DIFFUSION HANGING DROP METHOD WITH A PROTEIN CONCENTRATION OF 10 MG ML. THE RESERVOIR SOLUTION CONSISTED OF 1.6 M AMMONIUM SULFATE AND 0.1 M SODIUM ACETATE (",
    "0.2 SODIUM FLUORIDE",
    "ENZYME INCUBATED WITH 1 MM PLP AND 5 MM DTDP-3-AMINO-3",
    "SODIUM CITRATE 20 % (W V) PEG 4",
    "4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID BUFFER (HEPES)",
    "PEG 550 MME",
    "AMMONIUM ACETATE (",
    "~0.2 M CALCIUM CHLORIDE",
    "1:1 PROTEIN : 0.10 M HEPES",
    "H6NO4P AND 40% MPD;",
    "TRIS(HYDROXYMETHYL)AMINOMETHANE-HCL",
    "25 %V V PEGSM",
    "19-24 % PEG 400 100 MM TEA HCL PH=7.5 10 % (V V) ISOPROPANOL",
    "1:1 MIXTURE (2 UL TOTAL VOLUME) OF PROTEIN (20 MG ML) AND PRECIPITANT SOLUTION CONTAINING 100 MM TRIS HCL",
    "PROTEIN BUFFER 50MM TRIS",
    "POTASSIUM CHLORIDE AND 20% (W V) PEG3350",
    "MAGNESIUM CHLORIDE AND 20% (W V) PEG3350",
    "34-40% (V V) MPD",
    "12 %V V PEGSH",
    "PEG 3350 0.1 M BIS TRIS PROPANE",
    "PROTEIN: 16.2 MG ML",
    "MAGNESIUM ACETATE AND 28% PEG3350",
    "MORPHEUS SCREEN CONDITION H12: PRECIPITANT MIX 4: 25% V V MPD; 25% PEG 1000; 25% W V PEG 3350; BUFFER SYSTEM 3: 1.0M TRIS (BASE); BICINE",
    "JBS1D4: 30% PEG 2K MME",
    "CRYSTALS WERE OBTAINED FROM A RACEMIC MIX OF 7MG ML EACH OF L- AND D-PEPTIDE IN 0.2 M TRIMETHYLAMINE N-OXIDE DIHYDRATE",
    "VOL VOL 2-PROPANOL",
    "28%(W V)PEG3350 MME",
    "V V ISOPROPANOL",
    "SPG 28-32% PEG 1500 180 NL PROTEIN 10MG ML + 20 NL SEED 100 NL WELL SOLUTION",
    "(ND4)2SO4",
    "RIGAKU REAGENTS JCSG TOP96 SCREEN",
    "DL-GLUTAMIC ACID MONOHYDRATE",
    "GLUTAMIC ACID",
    "WELL SOLUTION: 0.1 M NA-CITRATE",
    "100-FOLD MOLAR INHIBITOR EXCESS",
    "PEG3350 0.1M HEPES",
    "8-12 % PEG8000",
    "1 UL 3.5 MG ML PROTEIN",
    "SPOP MATH WAS AT 24 MG ML AND 1:5 PROTEIN:53BP1 PEPTIDE MOLAR RATIO. CRYSTALS WERE GROWN BY THE HANGING DROP METHOD",
    "RESERVOIR SOLUTION: 0.1 M SODIUM CITRATE TRIBASIC DIHYDRATE",
    "CARBOXYLIC ACIDS",
    "DROPS CONTAINED 1 UL OF 20 MG ML STOASS-A MIXED WITH 1 UL OF RESERVOIR SOLUTION CONTAINING 30-31% (W V) PEG4000",
    "L-ARGININ",
    "SODIUM ACETATE 50 MM NACL 5 MM D-FRUCTOSE 10 MM SCLX8",
    "ACETATE 50 MM NACL 5 MM D-FRUCTOSE 15 MM SCLX8",
    "PROTEIN IN 180 MM NACL AND 20 MM SODIUM PHOSPHATE MIXED WITH 25% GLYCEROL",
    "HEPES SODIUM SALT 0.1 M",
    "CACODYLATE BIS TRIS PROPIONATE",
    "ZINC SULFATE HEPTAHYDRATE",
    "PROTEIN WAS CRYSTALLIZED FROM 25% PEG 3350",
    "PEGMME 2000",
    "1.8-2.0 M (NH4)2SO4",
    "PROTEIN 10-11 MG ML",
    "PALMITIC ACID",
    "TRIS-BICINE",
    "PEG D5",
    "MORPHEUS SCREEN",
    "LITHIUM CITRATE",
    "LYSOZYME CONTAINING 2.1MG ML (GLCNAC)4",
    "NA K PHOSPATE",
    "PEG4000 0.1 M MGCL2 0.1 M HEPES",
    "PEG8000 0.2 M NH4CL 0.1 M HEPES",
    "PROTEIN AT 5 MG ML IN 20 MM TRIS",
    "LISO4; 100 MM HEPES",
    "LISO4; 100 MM HEPES; 10 MM EDTA",
    "3",
    "SODIUM FORMATE + 0.1M CITRATE",
    "PEG6000 -- 10% ETHYLENE GLYCOL -- 0.1M TRIS",
    "18-22% PEG-8000",
    "23-26% MPD",
    "23-26 % MPD",
    "BISTRIS PH-6.2",
    "7.5 MG ML PROTEIN WITH 2.7 M AMMONIUM SULFATE",
    "NAH2PO4 1.0MKH2PO4 100MM TRIS_HCL PH=7.5",
    "(NH4)2SO4 200 MM K NA-TARTRATE 100 MM CITRATE",
    "PEG 4000 140 MM MG(NO3)2",
    "NH4HCO2 20 % PEG 4000",
    "KNO3 20 % PEG 3350",
    "(LI)2SO4 100 MM TRIS",
    "MES 6.5 PH",
    "BIS TRIS PROPANE 100 MM NA K PHOSPHATE 30 % PEG 3350",
    "PPG400 IN 80 MM BIS-TRIS",
    "PPG400 IN 80MM BIS-TRIS",
    "AMMONIUM SULFATESULPHATE",
    "BICINE-NA",
    "SOLUTION OF 1.5-1.7 M SODIUM CITRATE",
    "1 MICROLITER PROTEIN STOCK SOLUTION (8 MG ML CK2ALPHA",
    "PROTEIN SOLUTION: 7.5MG ML PROTEIN IN 5MM CACL2",
    "PROTEIN SOLUTION: 6.0MG ML PROTEIN IN 5MM CACL2",
    "PROTEIN SOLUTION: 5.0MG ML PROTEIN IN 5MM CACL2",
    "1.5-2.0 MM PROTEIN IN 20 MM TRIS SULFATE",
    "PROTEIN SOLUTION: 6MG ML PROTEIN IN 5 MM CACL2",
    "PROTEIN SOLUTION: 6MG ML PROTEIN IN 5MM CACL2",
    "7-12 % PEG 8000",
    "BIS-TRIS PROPANE BUFFER AT",
    "ENZYME TREATED WITH 200 UM INHIBITOR AT 37C FOR 16 HOURS AND SUBSEQUENTLY MIXED 1:1 WITH 20% PEG3350",
    "SUCCINIC ACID (",
    "MORPHEUS: 0",
    "1.6 1.8 M (NH4)2SO2 AND 50MM HEPES BUFFER",
    "1.6 1.8 M (NH4)2SO4 AND 50MM HEPES BUFFER",
    "1.6 1.8 M (NH4)2SO3 AND 50MM HEPES BUFFER",
    "(NH4)2SO4 AND 50MM HEPES BUFFER",
    "COMPLEX CRYSTALS WERE GROWN IN DROPS CONTAINING 1.5 UL OF PROTEIN SOLUTION (14 MG ML PROTEIN IN THE BUFFER 10 MM HEPES",
    "3350",
    "STMAA.00944.A.B1.PW38722 AT 29.2 MG ML AGAINST MCSG1 SCREEN CONDITION G5: 0.1 M BISTRIS HCL",
    "PEG 3K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 9% PEG8K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 11% PEG8K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 12% PEG8K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 8% PEG8K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 17% PEG8K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 18% PEG8K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 10% PEG8K",
    "POTASSIUM PHOSPHATE MONOBASIC -- 14% PEG8K",
    "D00-D0 50 MG ML. IN 400MM NACL 10 MM HEPES",
    "METHYLATED PROTEIN. 0.1M TRIS 8.5",
    "PEG4000 0.205 M SODIUM ACETATE 0.1 M TRIS",
    "BUFFER: 0.1 M MES (",
    "BUFFER: 0.1 M SODIUM ACETATE TRIHYDRATE (",
    "HEPES-7.5",
    "CRYSTALLIZATION EXPERIMENTS WERE SET UP WITH SMPUTA (6 MG ML) AND TRANS-4-HYDROXY-D-PROLINE (50 MM) IN A BUFFER CONTAINING 50 MM TRIS (",
    "CRYSTALLIZATION EXPERIMENTS WERE SET UP WITH SMPUTA (6 MG ML)",
    "CRYSTALLIZATION EXPERIMENTS WERE SET UP WITH SMPUTA (6 MG ML) AND NADH (10 MM) IN A BUFFER CONTAINING 50 MM TRIS (",
    "32.5 MG ML-1 PROTEIN MIXED WITH COA-AC-MVNAL (2.5 MM); DROPS (400 NL): 1:1 MIX OF (20 MM HEPES",
    "LI CAC",
    "PEG 3350 25%",
    "25%-27% (V V) PEG 3350",
    "RESERVOIR SOLUTION: 1.6 M (NH4)2SO4",
    "POLYETHYLENE GLYCOL MONOMETHYL ETHER 2",
    "CRYSTALLIZATION SET-UPS WERE MADE BY MIXING 4 UL OF 350 UM RNA SOLUTION [1 MM NA 2 EDTA (",
    "RNA WAS DISSOLVED IN 1 MM NA2 EDTA (",
    "SODIUM HEPES MOPS BUFFER"
  ],
  "n_methods": 14,
  "n_components": 2399
}